#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Examining resting-state functional connectivity in first-episode schizophrenia with 7T fMRI and MEG Schizophrenia is often characterized by dysconnections in the brain, which can be estimated via functional connectivity analyses.
1-1	0-9	Examining	_
1-2	10-23	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-3	24-34	functional	_
1-4	35-47	connectivity	_
1-5	48-50	in	_
1-6	51-64	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
1-7	65-78	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
1-8	79-83	with	_
1-9	84-86	7T	_
1-10	87-91	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-11	92-95	and	_
1-12	96-99	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
1-13	100-113	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
1-14	114-116	is	_
1-15	117-122	often	_
1-16	123-136	characterized	_
1-17	137-139	by	_
1-18	140-154	dysconnections	_
1-19	155-157	in	_
1-20	158-161	the	_
1-21	162-167	brain	_
1-22	168-169	,	_
1-23	170-175	which	_
1-24	176-179	can	_
1-25	180-182	be	_
1-26	183-192	estimated	_
1-27	193-196	via	_
1-28	197-207	functional	_
1-29	208-220	connectivity	_
1-30	221-229	analyses	_
1-31	230-231	.	_

Text=Commonly measured using resting-state functional magnetic resonance imaging (fMRI) in order to characterize the intrinsic or baseline function of the brain, fMRI functional connectivity has significantly contributed to the understanding of schizophrenia.
2-1	232-240	Commonly	_
2-2	241-249	measured	_
2-3	250-255	using	_
2-4	256-269	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-5	270-280	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-6	281-289	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-7	290-299	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-8	300-307	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-9	308-309	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-10	310-314	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-11	315-316	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-12	317-319	in	_
2-13	320-325	order	_
2-14	326-328	to	_
2-15	329-341	characterize	_
2-16	342-345	the	_
2-17	346-355	intrinsic	_
2-18	356-358	or	_
2-19	359-367	baseline	_
2-20	368-376	function	_
2-21	377-379	of	_
2-22	380-383	the	_
2-23	384-389	brain	_
2-24	390-391	,	_
2-25	392-396	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-26	397-407	functional	_
2-27	408-420	connectivity	_
2-28	421-424	has	_
2-29	425-438	significantly	_
2-30	439-450	contributed	_
2-31	451-453	to	_
2-32	454-457	the	_
2-33	458-471	understanding	_
2-34	472-474	of	_
2-35	475-488	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-36	489-490	.	_

Text=However, these measures may not capture the full extent of functional connectivity abnormalities in schizophrenia as fMRI is temporally limited by the hemodynamic response.
3-1	491-498	However	_
3-2	499-500	,	_
3-3	501-506	these	_
3-4	507-515	measures	_
3-5	516-519	may	_
3-6	520-523	not	_
3-7	524-531	capture	_
3-8	532-535	the	_
3-9	536-540	full	_
3-10	541-547	extent	_
3-11	548-550	of	_
3-12	551-561	functional	_
3-13	562-574	connectivity	_
3-14	575-588	abnormalities	_
3-15	589-591	in	_
3-16	592-605	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-17	606-608	as	_
3-18	609-613	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
3-19	614-616	is	_
3-20	617-627	temporally	_
3-21	628-635	limited	_
3-22	636-638	by	_
3-23	639-642	the	_
3-24	643-654	hemodynamic	_
3-25	655-663	response	_
3-26	664-665	.	_

Text=In order to extend fMRI functional connectivity findings, the complementary modality of magnetoencephalography (MEG) can be utilized to capture electrophysiological functional connectivity abnormalities in schizophrenia that are not obtainable with fMRI.
4-1	666-668	In	_
4-2	669-674	order	_
4-3	675-677	to	_
4-4	678-684	extend	_
4-5	685-689	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-6	690-700	functional	_
4-7	701-713	connectivity	_
4-8	714-722	findings	_
4-9	723-724	,	_
4-10	725-728	the	_
4-11	729-742	complementary	_
4-12	743-751	modality	_
4-13	752-754	of	_
4-14	755-777	magnetoencephalography	_
4-15	778-779	(	_
4-16	780-783	MEG	_
4-17	784-785	)	_
4-18	786-789	can	_
4-19	790-792	be	_
4-20	793-801	utilized	_
4-21	802-804	to	_
4-22	805-812	capture	_
4-23	813-833	electrophysiological	_
4-24	834-844	functional	_
4-25	845-857	connectivity	_
4-26	858-871	abnormalities	_
4-27	872-874	in	_
4-28	875-888	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-29	889-893	that	_
4-30	894-897	are	_
4-31	898-901	not	_
4-32	902-912	obtainable	_
4-33	913-917	with	_
4-34	918-922	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-35	923-924	.	_

Text=Therefore, we implemented a multimodal functional connectivity analysis using resting-state 7 Tesla fMRI and MEG data in a sample of first-episode patients with schizophrenia (n = 19) and healthy controls (n = 24).
5-1	925-934	Therefore	_
5-2	935-936	,	_
5-3	937-939	we	_
5-4	940-951	implemented	_
5-5	952-953	a	_
5-6	954-964	multimodal	_
5-7	965-975	functional	_
5-8	976-988	connectivity	_
5-9	989-997	analysis	_
5-10	998-1003	using	_
5-11	1004-1017	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-12	1018-1019	7	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-13	1020-1025	Tesla	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-14	1026-1030	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-15	1031-1034	and	_
5-16	1035-1038	MEG	_
5-17	1039-1043	data	_
5-18	1044-1046	in	_
5-19	1047-1048	a	_
5-20	1049-1055	sample	_
5-21	1056-1058	of	_
5-22	1059-1072	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
5-23	1073-1081	patients	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
5-24	1082-1086	with	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
5-25	1087-1100	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
5-26	1101-1102	(	_
5-27	1103-1104	n	_
5-28	1105-1106	=	_
5-29	1107-1109	19	_
5-30	1110-1111	)	_
5-31	1112-1115	and	_
5-32	1116-1123	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-33	1124-1132	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-34	1133-1134	(	_
5-35	1135-1136	n	_
5-36	1137-1138	=	_
5-37	1139-1141	24	_
5-38	1142-1143	)	_
5-39	1144-1145	.	_

Text=fMRI and MEG data were decomposed into components reflecting resting state networks using a group spatial independent component analysis.
6-1	1146-1150	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-2	1151-1154	and	_
6-3	1155-1158	MEG	_
6-4	1159-1163	data	_
6-5	1164-1168	were	_
6-6	1169-1179	decomposed	_
6-7	1180-1184	into	_
6-8	1185-1195	components	_
6-9	1196-1206	reflecting	_
6-10	1207-1214	resting	_
6-11	1215-1220	state	_
6-12	1221-1229	networks	_
6-13	1230-1235	using	_
6-14	1236-1237	a	_
6-15	1238-1243	group	_
6-16	1244-1251	spatial	_
6-17	1252-1263	independent	_
6-18	1264-1273	component	_
6-19	1274-1282	analysis	_
6-20	1283-1284	.	_

Text=Functional connectivity between resting-state networks was computed and group differences were observed.
7-1	1285-1295	Functional	_
7-2	1296-1308	connectivity	_
7-3	1309-1316	between	_
7-4	1317-1330	resting-state	_
7-5	1331-1339	networks	_
7-6	1340-1343	was	_
7-7	1344-1352	computed	_
7-8	1353-1356	and	_
7-9	1357-1362	group	_
7-10	1363-1374	differences	_
7-11	1375-1379	were	_
7-12	1380-1388	observed	_
7-13	1389-1390	.	_

Text=In fMRI, patients demonstrated hyperconnectivity between subcortical and auditory networks, as well as hypoconnectivity between interhemispheric homotopic sensorimotor network components.
8-1	1391-1393	In	_
8-2	1394-1398	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
8-3	1399-1400	,	_
8-4	1401-1409	patients	_
8-5	1410-1422	demonstrated	_
8-6	1423-1440	hyperconnectivity	_
8-7	1441-1448	between	_
8-8	1449-1460	subcortical	_
8-9	1461-1464	and	_
8-10	1465-1473	auditory	_
8-11	1474-1482	networks	_
8-12	1483-1484	,	_
8-13	1485-1487	as	_
8-14	1488-1492	well	_
8-15	1493-1495	as	_
8-16	1496-1512	hypoconnectivity	_
8-17	1513-1520	between	_
8-18	1521-1537	interhemispheric	_
8-19	1538-1547	homotopic	_
8-20	1548-1560	sensorimotor	_
8-21	1561-1568	network	_
8-22	1569-1579	components	_
8-23	1580-1581	.	_

Text=In MEG, patients demonstrated hypoconnectivity between sensorimotor and task positive networks in the delta frequency band.
9-1	1582-1584	In	_
9-2	1585-1588	MEG	_
9-3	1589-1590	,	_
9-4	1591-1599	patients	_
9-5	1600-1612	demonstrated	_
9-6	1613-1629	hypoconnectivity	_
9-7	1630-1637	between	_
9-8	1638-1650	sensorimotor	_
9-9	1651-1654	and	_
9-10	1655-1659	task	_
9-11	1660-1668	positive	_
9-12	1669-1677	networks	_
9-13	1678-1680	in	_
9-14	1681-1684	the	_
9-15	1685-1690	delta	_
9-16	1691-1700	frequency	_
9-17	1701-1705	band	_
9-18	1706-1707	.	_

Text=Results not only support the dysconnectivity hypothesis of schizophrenia, but also suggest the importance of jointly examining multimodal neuroimaging data as critical disorder-related information may not be detectable in a single modality alone.
10-1	1708-1715	Results	_
10-2	1716-1719	not	_
10-3	1720-1724	only	_
10-4	1725-1732	support	_
10-5	1733-1736	the	_
10-6	1737-1752	dysconnectivity	_
10-7	1753-1763	hypothesis	_
10-8	1764-1766	of	_
10-9	1767-1780	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-10	1781-1782	,	_
10-11	1783-1786	but	_
10-12	1787-1791	also	_
10-13	1792-1799	suggest	_
10-14	1800-1803	the	_
10-15	1804-1814	importance	_
10-16	1815-1817	of	_
10-17	1818-1825	jointly	_
10-18	1826-1835	examining	_
10-19	1836-1846	multimodal	_
10-20	1847-1859	neuroimaging	_
10-21	1860-1864	data	_
10-22	1865-1867	as	_
10-23	1868-1876	critical	_
10-24	1877-1893	disorder-related	_
10-25	1894-1905	information	_
10-26	1906-1909	may	_
10-27	1910-1913	not	_
10-28	1914-1916	be	_
10-29	1917-1927	detectable	_
10-30	1928-1930	in	_
10-31	1931-1932	a	_
10-32	1933-1939	single	_
10-33	1940-1948	modality	_
10-34	1949-1954	alone	_
10-35	1955-1956	.	_

Text=Highlights Altered subcortical-auditory fMRI functional connectivity at rest in first-episode.
11-1	1957-1967	Highlights	_
11-2	1968-1975	Altered	_
11-3	1976-1996	subcortical-auditory	_
11-4	1997-2001	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-5	2002-2012	functional	_
11-6	2013-2025	connectivity	_
11-7	2026-2028	at	_
11-8	2029-2033	rest	_
11-9	2034-2036	in	_
11-10	2037-2050	first-episode	_
11-11	2051-2052	.	_

Text=fMRI sensorimotor interhemispheric homotopic connectivity altered in first-episode.
12-1	2053-2057	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
12-2	2058-2070	sensorimotor	_
12-3	2071-2087	interhemispheric	_
12-4	2088-2097	homotopic	_
12-5	2098-2110	connectivity	_
12-6	2111-2118	altered	_
12-7	2119-2121	in	_
12-8	2122-2135	first-episode	_
12-9	2136-2137	.	_

Text=Sensorimotor-task positive connectivity alterations in delta frequency band.
13-1	2138-2155	Sensorimotor-task	_
13-2	2156-2164	positive	_
13-3	2165-2177	connectivity	_
13-4	2178-2189	alterations	_
13-5	2190-2192	in	_
13-6	2193-2198	delta	_
13-7	2199-2208	frequency	_
13-8	2209-2213	band	_
13-9	2214-2215	.	_

Text=Materials and methods Participants Minimally treated first-episode patients with schizophrenia were recruited from the University of Alabama at Birmingham (UAB) emergency room, inpatient units, and various outpatient clinics.
14-1	2216-2225	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
14-2	2226-2229	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
14-3	2230-2237	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
14-4	2238-2250	Participants	_
14-5	2251-2260	Minimally	_
14-6	2261-2268	treated	_
14-7	2269-2282	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
14-8	2283-2291	patients	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
14-9	2292-2296	with	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
14-10	2297-2310	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
14-11	2311-2315	were	_
14-12	2316-2325	recruited	_
14-13	2326-2330	from	_
14-14	2331-2334	the	_
14-15	2335-2345	University	_
14-16	2346-2348	of	_
14-17	2349-2356	Alabama	_
14-18	2357-2359	at	_
14-19	2360-2370	Birmingham	_
14-20	2371-2372	(	_
14-21	2373-2376	UAB	_
14-22	2377-2378	)	_
14-23	2379-2388	emergency	_
14-24	2389-2393	room	_
14-25	2394-2395	,	_
14-26	2396-2405	inpatient	_
14-27	2406-2411	units	_
14-28	2412-2413	,	_
14-29	2414-2417	and	_
14-30	2418-2425	various	_
14-31	2426-2436	outpatient	_
14-32	2437-2444	clinics	_
14-33	2445-2446	.	_

Text=Informed consent to participate in this UAB Institutional Review Board (IRB) approved study was obtained following evaluation of competency to provide informed consent.
15-1	2447-2455	Informed	_
15-2	2456-2463	consent	_
15-3	2464-2466	to	_
15-4	2467-2478	participate	_
15-5	2479-2481	in	_
15-6	2482-2486	this	_
15-7	2487-2490	UAB	_
15-8	2491-2504	Institutional	_
15-9	2505-2511	Review	_
15-10	2512-2517	Board	_
15-11	2518-2519	(	_
15-12	2520-2523	IRB	_
15-13	2524-2525	)	_
15-14	2526-2534	approved	_
15-15	2535-2540	study	_
15-16	2541-2544	was	_
15-17	2545-2553	obtained	_
15-18	2554-2563	following	_
15-19	2564-2574	evaluation	_
15-20	2575-2577	of	_
15-21	2578-2588	competency	_
15-22	2589-2591	to	_
15-23	2592-2599	provide	_
15-24	2600-2608	informed	_
15-25	2609-2616	consent	_
15-26	2617-2618	.	_

Text=Additionally, healthy controls matched on age, gender, parental socioeconomic status (SES), years of education, and smoking status were enrolled in the study.
16-1	2619-2631	Additionally	_
16-2	2632-2633	,	_
16-3	2634-2641	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
16-4	2642-2650	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
16-5	2651-2658	matched	_
16-6	2659-2661	on	_
16-7	2662-2665	age	_
16-8	2666-2667	,	_
16-9	2668-2674	gender	_
16-10	2675-2676	,	_
16-11	2677-2685	parental	_
16-12	2686-2699	socioeconomic	_
16-13	2700-2706	status	_
16-14	2707-2708	(	_
16-15	2709-2712	SES	_
16-16	2713-2714	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
16-17	2715-2716	,	_
16-18	2717-2722	years	_
16-19	2723-2725	of	_
16-20	2726-2735	education	_
16-21	2736-2737	,	_
16-22	2738-2741	and	_
16-23	2742-2749	smoking	_
16-24	2750-2756	status	_
16-25	2757-2761	were	_
16-26	2762-2770	enrolled	_
16-27	2771-2773	in	_
16-28	2774-2777	the	_
16-29	2778-2783	study	_
16-30	2784-2785	.	_

Text=Diagnoses were established with a review of medical records and evaluation by two board certified psychiatrists (ACL and NVK) and confirmed using the Diagnostic Interview for Genetic Studies.
17-1	2786-2795	Diagnoses	_
17-2	2796-2800	were	_
17-3	2801-2812	established	_
17-4	2813-2817	with	_
17-5	2818-2819	a	_
17-6	2820-2826	review	_
17-7	2827-2829	of	_
17-8	2830-2837	medical	_
17-9	2838-2845	records	_
17-10	2846-2849	and	_
17-11	2850-2860	evaluation	_
17-12	2861-2863	by	_
17-13	2864-2867	two	_
17-14	2868-2873	board	_
17-15	2874-2883	certified	_
17-16	2884-2897	psychiatrists	_
17-17	2898-2899	(	_
17-18	2900-2903	ACL	_
17-19	2904-2907	and	_
17-20	2908-2911	NVK	_
17-21	2912-2913	)	_
17-22	2914-2917	and	_
17-23	2918-2927	confirmed	_
17-24	2928-2933	using	_
17-25	2934-2937	the	_
17-26	2938-2948	Diagnostic	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies
17-27	2949-2958	Interview	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies
17-28	2959-2962	for	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies
17-29	2963-2970	Genetic	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies
17-30	2971-2978	Studies	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies
17-31	2979-2980	.	_

Text=Exclusion criteria for this study included the presence of major medical or neurological conditions, history of head trauma with loss of consciousness, substance abuse within six months of imaging (excluding nicotine), pregnancy, MRI contraindications, and use of medication altering brain function.
18-1	2981-2990	Exclusion	_
18-2	2991-2999	criteria	_
18-3	3000-3003	for	_
18-4	3004-3008	this	_
18-5	3009-3014	study	_
18-6	3015-3023	included	_
18-7	3024-3027	the	_
18-8	3028-3036	presence	_
18-9	3037-3039	of	_
18-10	3040-3045	major	_
18-11	3046-3053	medical	_
18-12	3054-3056	or	_
18-13	3057-3069	neurological	_
18-14	3070-3080	conditions	_
18-15	3081-3082	,	_
18-16	3083-3090	history	_
18-17	3091-3093	of	_
18-18	3094-3098	head	_
18-19	3099-3105	trauma	_
18-20	3106-3110	with	_
18-21	3111-3115	loss	_
18-22	3116-3118	of	_
18-23	3119-3132	consciousness	_
18-24	3133-3134	,	_
18-25	3135-3144	substance	_
18-26	3145-3150	abuse	_
18-27	3151-3157	within	_
18-28	3158-3161	six	_
18-29	3162-3168	months	_
18-30	3169-3171	of	_
18-31	3172-3179	imaging	_
18-32	3180-3181	(	_
18-33	3182-3191	excluding	_
18-34	3192-3200	nicotine	_
18-35	3201-3202	)	_
18-36	3203-3204	,	_
18-37	3205-3214	pregnancy	_
18-38	3215-3216	,	_
18-39	3217-3220	MRI	_
18-40	3221-3238	contraindications	_
18-41	3239-3240	,	_
18-42	3241-3244	and	_
18-43	3245-3248	use	_
18-44	3249-3251	of	_
18-45	3252-3262	medication	_
18-46	3263-3271	altering	_
18-47	3272-3277	brain	_
18-48	3278-3286	function	_
18-49	3287-3288	.	_

Text=Exclusion criteria for healthy controls also included a personal history of Axis I disorders or in first-degree relatives.
19-1	3289-3298	Exclusion	_
19-2	3299-3307	criteria	_
19-3	3308-3311	for	_
19-4	3312-3319	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-5	3320-3328	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-6	3329-3333	also	_
19-7	3334-3342	included	_
19-8	3343-3344	a	_
19-9	3345-3353	personal	_
19-10	3354-3361	history	_
19-11	3362-3364	of	_
19-12	3365-3369	Axis	_
19-13	3370-3371	I	_
19-14	3372-3381	disorders	_
19-15	3382-3384	or	_
19-16	3385-3387	in	_
19-17	3388-3400	first-degree	_
19-18	3401-3410	relatives	_
19-19	3411-3412	.	_

Text=A total of 23 first-episode patients with schizophrenia were enrolled in the study.
20-1	3413-3414	A	_
20-2	3415-3420	total	_
20-3	3421-3423	of	_
20-4	3424-3426	23	_
20-5	3427-3440	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
20-6	3441-3449	patients	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
20-7	3450-3454	with	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
20-8	3455-3468	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
20-9	3469-3473	were	_
20-10	3474-3482	enrolled	_
20-11	3483-3485	in	_
20-12	3486-3489	the	_
20-13	3490-3495	study	_
20-14	3496-3497	.	_

Text=Of these, fMRI resting-state data for 19 patients remained for analysis as one subject was too large, one subject was unable to complete the scan due to scanner intolerability, one subject was excluded due to poor scan quality, and one subject did not complete a resting-state fMRI scan.
21-1	3498-3500	Of	_
21-2	3501-3506	these	_
21-3	3507-3508	,	_
21-4	3509-3513	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
21-5	3514-3527	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
21-6	3528-3532	data	_
21-7	3533-3536	for	_
21-8	3537-3539	19	_
21-9	3540-3548	patients	_
21-10	3549-3557	remained	_
21-11	3558-3561	for	_
21-12	3562-3570	analysis	_
21-13	3571-3573	as	_
21-14	3574-3577	one	_
21-15	3578-3585	subject	_
21-16	3586-3589	was	_
21-17	3590-3593	too	_
21-18	3594-3599	large	_
21-19	3600-3601	,	_
21-20	3602-3605	one	_
21-21	3606-3613	subject	_
21-22	3614-3617	was	_
21-23	3618-3624	unable	_
21-24	3625-3627	to	_
21-25	3628-3636	complete	_
21-26	3637-3640	the	_
21-27	3641-3645	scan	_
21-28	3646-3649	due	_
21-29	3650-3652	to	_
21-30	3653-3660	scanner	_
21-31	3661-3675	intolerability	_
21-32	3676-3677	,	_
21-33	3678-3681	one	_
21-34	3682-3689	subject	_
21-35	3690-3693	was	_
21-36	3694-3702	excluded	_
21-37	3703-3706	due	_
21-38	3707-3709	to	_
21-39	3710-3714	poor	_
21-40	3715-3719	scan	_
21-41	3720-3727	quality	_
21-42	3728-3729	,	_
21-43	3730-3733	and	_
21-44	3734-3737	one	_
21-45	3738-3745	subject	_
21-46	3746-3749	did	_
21-47	3750-3753	not	_
21-48	3754-3762	complete	_
21-49	3763-3764	a	_
21-50	3765-3778	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
21-51	3779-3783	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
21-52	3784-3788	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
21-53	3789-3790	.	_

Text=MEG data for 19 patients remained for analysis as one subject was too large, one subject was lost to follow-up, one subject was hospitalized long-term, and data for one subject lacked head position sensor information.
22-1	3791-3794	MEG	_
22-2	3795-3799	data	_
22-3	3800-3803	for	_
22-4	3804-3806	19	_
22-5	3807-3815	patients	_
22-6	3816-3824	remained	_
22-7	3825-3828	for	_
22-8	3829-3837	analysis	_
22-9	3838-3840	as	_
22-10	3841-3844	one	_
22-11	3845-3852	subject	_
22-12	3853-3856	was	_
22-13	3857-3860	too	_
22-14	3861-3866	large	_
22-15	3867-3868	,	_
22-16	3869-3872	one	_
22-17	3873-3880	subject	_
22-18	3881-3884	was	_
22-19	3885-3889	lost	_
22-20	3890-3892	to	_
22-21	3893-3902	follow-up	_
22-22	3903-3904	,	_
22-23	3905-3908	one	_
22-24	3909-3916	subject	_
22-25	3917-3920	was	_
22-26	3921-3933	hospitalized	_
22-27	3934-3943	long-term	_
22-28	3944-3945	,	_
22-29	3946-3949	and	_
22-30	3950-3954	data	_
22-31	3955-3958	for	_
22-32	3959-3962	one	_
22-33	3963-3970	subject	_
22-34	3971-3977	lacked	_
22-35	3978-3982	head	_
22-36	3983-3991	position	_
22-37	3992-3998	sensor	_
22-38	3999-4010	information	_
22-39	4011-4012	.	_

Text=A total of 24 matched healthy controls were enrolled in the study.
23-1	4013-4014	A	_
23-2	4015-4020	total	_
23-3	4021-4023	of	_
23-4	4024-4026	24	_
23-5	4027-4034	matched	_
23-6	4035-4042	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
23-7	4043-4051	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
23-8	4052-4056	were	_
23-9	4057-4065	enrolled	_
23-10	4066-4068	in	_
23-11	4069-4072	the	_
23-12	4073-4078	study	_
23-13	4079-4080	.	_

Text=Of the 24 controls enrolled, fMRI resting-state data for 21 subjects remained for analysis as three subjects did not complete a resting-state fMRI scan.
24-1	4081-4083	Of	_
24-2	4084-4087	the	_
24-3	4088-4090	24	_
24-4	4091-4099	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
24-5	4100-4108	enrolled	_
24-6	4109-4110	,	_
24-7	4111-4115	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
24-8	4116-4129	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
24-9	4130-4134	data	_
24-10	4135-4138	for	_
24-11	4139-4141	21	_
24-12	4142-4150	subjects	_
24-13	4151-4159	remained	_
24-14	4160-4163	for	_
24-15	4164-4172	analysis	_
24-16	4173-4175	as	_
24-17	4176-4181	three	_
24-18	4182-4190	subjects	_
24-19	4191-4194	did	_
24-20	4195-4198	not	_
24-21	4199-4207	complete	_
24-22	4208-4209	a	_
24-23	4210-4223	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
24-24	4224-4228	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
24-25	4229-4233	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
24-26	4234-4235	.	_

Text=MEG data for 24 controls remained for MEG analysis.
25-1	4236-4239	MEG	_
25-2	4240-4244	data	_
25-3	4245-4248	for	_
25-4	4249-4251	24	_
25-5	4252-4260	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
25-6	4261-4269	remained	_
25-7	4270-4273	for	_
25-8	4274-4277	MEG	_
25-9	4278-4286	analysis	_
25-10	4287-4288	.	_

Text=Symptom severity was assessed using the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Negative Symptoms (SANS), and the Scale for the Assessment of Positive Symptoms (SAPS).
26-1	4289-4296	Symptom	_
26-2	4297-4305	severity	_
26-3	4306-4309	was	_
26-4	4310-4318	assessed	_
26-5	4319-4324	using	_
26-6	4325-4328	the	_
26-7	4329-4334	Brief	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
26-8	4335-4346	Psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
26-9	4347-4353	Rating	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
26-10	4354-4359	Scale	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
26-11	4360-4361	(	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
26-12	4362-4366	BPRS	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
26-13	4367-4368	)	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
26-14	4369-4370	,	_
26-15	4371-4374	the	_
26-16	4375-4380	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-17	4381-4384	for	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-18	4385-4388	the	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-19	4389-4399	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-20	4400-4402	of	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-21	4403-4411	Negative	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-22	4412-4420	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-23	4421-4422	(	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-24	4423-4427	SANS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-25	4428-4429	)	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
26-26	4430-4431	,	_
26-27	4432-4435	and	_
26-28	4436-4439	the	_
26-29	4440-4445	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-30	4446-4449	for	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-31	4450-4453	the	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-32	4454-4464	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-33	4465-4467	of	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-34	4468-4476	Positive	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-35	4477-4485	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-36	4486-4487	(	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-37	4488-4492	SAPS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-38	4493-4494	)	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
26-39	4495-4496	.	_

Text=The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was used to assess cognitive function for healthy controls and patients.
27-1	4497-4500	The	_
27-2	4501-4511	Repeatable	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-3	4512-4519	Battery	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-4	4520-4523	for	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-5	4524-4527	the	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-6	4528-4538	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-7	4539-4541	of	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-8	4542-4560	Neuropsychological	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-9	4561-4567	Status	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-10	4568-4569	(	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-11	4570-4575	RBANS	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-12	4576-4577	)	http://maven.renci.org/NeuroBridge/neurobridge#DevelopmentalNeuropsychologicalAssessment
27-13	4578-4581	was	_
27-14	4582-4586	used	_
27-15	4587-4589	to	_
27-16	4590-4596	assess	_
27-17	4597-4606	cognitive	_
27-18	4607-4615	function	_
27-19	4616-4619	for	_
27-20	4620-4627	healthy	_
27-21	4628-4636	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
27-22	4637-4640	and	_
27-23	4641-4649	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
27-24	4650-4651	.	_

Text=Functional MRI analysis fMRI scanning parameters All scans were performed at the Auburn University MRI Research Center on a whole-body 7 T Siemens MAGNETOM MRI scanner (Siemens Healthineers, Erlangen, Germany), with a 32-channel head coil.
28-1	4652-4662	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
28-2	4663-4666	MRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
28-3	4667-4675	analysis	_
28-4	4676-4680	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
28-5	4681-4689	scanning	_
28-6	4690-4700	parameters	_
28-7	4701-4704	All	_
28-8	4705-4710	scans	_
28-9	4711-4715	were	_
28-10	4716-4725	performed	_
28-11	4726-4728	at	_
28-12	4729-4732	the	_
28-13	4733-4739	Auburn	_
28-14	4740-4750	University	_
28-15	4751-4754	MRI	_
28-16	4755-4763	Research	_
28-17	4764-4770	Center	_
28-18	4771-4773	on	_
28-19	4774-4775	a	_
28-20	4776-4786	whole-body	_
28-21	4787-4788	7	_
28-22	4789-4790	T	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
28-23	4791-4798	Siemens	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
28-24	4799-4807	MAGNETOM	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
28-25	4808-4811	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
28-26	4812-4819	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
28-27	4820-4821	(	_
28-28	4822-4829	Siemens	_
28-29	4830-4842	Healthineers	_
28-30	4843-4844	,	_
28-31	4845-4853	Erlangen	_
28-32	4854-4855	,	_
28-33	4856-4863	Germany	_
28-34	4864-4865	)	_
28-35	4866-4867	,	_
28-36	4868-4872	with	_
28-37	4873-4874	a	_
28-38	4875-4885	32-channel	_
28-39	4886-4890	head	_
28-40	4891-4895	coil	_
28-41	4896-4897	.	_

Text=High-resolution structural scans were acquired using a 3-dimensional T1-weighted magnetization-prepared rapid acquisition gradient-echo sequence (MPRAGE; 256 slices, repetition time/echo time/inversion time [TR/TE/TI] = 2000/2.89/1050 ms, 7° flip angle, 190 mm field of view, 0.7 mm isotropic voxels, base resolution = 256, sagittal acquisition, GRAPPA acceleration factor = 2).
29-1	4898-4913	High-resolution	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
29-2	4914-4924	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
29-3	4925-4930	scans	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
29-4	4931-4935	were	_
29-5	4936-4944	acquired	_
29-6	4945-4950	using	_
29-7	4951-4952	a	_
29-8	4953-4966	3-dimensional	_
29-9	4967-4978	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-10	4979-5001	magnetization-prepared	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-11	5002-5007	rapid	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-12	5008-5019	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-13	5020-5033	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-14	5034-5042	sequence	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
29-15	5043-5044	(	_
29-16	5045-5051	MPRAGE	_
29-17	5052-5053	;	_
29-18	5054-5057	256	_
29-19	5058-5064	slices	_
29-20	5065-5066	,	_
29-21	5067-5077	repetition	_
29-22	5078-5087	time/echo	_
29-23	5088-5102	time/inversion	_
29-24	5103-5107	time	_
29-25	5108-5109	[	_
29-26	5110-5118	TR/TE/TI	_
29-27	5119-5120	]	_
29-28	5121-5122	=	_
29-29	5123-5137	2000/2.89/1050	_
29-30	5138-5140	ms	_
29-31	5141-5142	,	_
29-32	5143-5145	7°	_
29-33	5146-5150	flip	_
29-34	5151-5156	angle	_
29-35	5157-5158	,	_
29-36	5159-5162	190	_
29-37	5163-5165	mm	_
29-38	5166-5171	field	_
29-39	5172-5174	of	_
29-40	5175-5179	view	_
29-41	5180-5181	,	_
29-42	5182-5185	0.7	_
29-43	5186-5188	mm	_
29-44	5189-5198	isotropic	_
29-45	5199-5205	voxels	_
29-46	5206-5207	,	_
29-47	5208-5212	base	_
29-48	5213-5223	resolution	_
29-49	5224-5225	=	_
29-50	5226-5229	256	_
29-51	5230-5231	,	_
29-52	5232-5240	sagittal	_
29-53	5241-5252	acquisition	_
29-54	5253-5254	,	_
29-55	5255-5261	GRAPPA	_
29-56	5262-5274	acceleration	_
29-57	5275-5281	factor	_
29-58	5282-5283	=	_
29-59	5284-5285	2	_
29-60	5286-5287	)	_
29-61	5288-5289	.	_

Text=Resting-state fMRI scans were acquired using a gradient recalled echo-planar imaging sequence (TR/TE = 3000/28 ms, 70° flip angle, 200 mm field of view, 37 slices, 0.85 mm × 0.85 mm × 1.8 mm voxels, iPAT GRAPPA acceleration factor = 3, base resolution = 234, interleaved acquisition, A> P phase encode direction, 1 ms echo spacing, gap = 1.08 mm).
30-1	5290-5303	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
30-2	5304-5308	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
30-3	5309-5314	scans	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
30-4	5315-5319	were	_
30-5	5320-5328	acquired	_
30-6	5329-5334	using	_
30-7	5335-5336	a	_
30-8	5337-5345	gradient	_
30-9	5346-5354	recalled	_
30-10	5355-5366	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
30-11	5367-5374	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
30-12	5375-5383	sequence	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
30-13	5384-5385	(	_
30-14	5386-5391	TR/TE	_
30-15	5392-5393	=	_
30-16	5394-5401	3000/28	_
30-17	5402-5404	ms	_
30-18	5405-5406	,	_
30-19	5407-5410	70°	_
30-20	5411-5415	flip	_
30-21	5416-5421	angle	_
30-22	5422-5423	,	_
30-23	5424-5427	200	_
30-24	5428-5430	mm	_
30-25	5431-5436	field	_
30-26	5437-5439	of	_
30-27	5440-5444	view	_
30-28	5445-5446	,	_
30-29	5447-5449	37	_
30-30	5450-5456	slices	_
30-31	5457-5458	,	_
30-32	5459-5463	0.85	_
30-33	5464-5466	mm	_
30-34	5467-5468	×	_
30-35	5469-5473	0.85	_
30-36	5474-5476	mm	_
30-37	5477-5478	×	_
30-38	5479-5482	1.8	_
30-39	5483-5485	mm	_
30-40	5486-5492	voxels	_
30-41	5493-5494	,	_
30-42	5495-5499	iPAT	_
30-43	5500-5506	GRAPPA	_
30-44	5507-5519	acceleration	_
30-45	5520-5526	factor	_
30-46	5527-5528	=	_
30-47	5529-5530	3	_
30-48	5531-5532	,	_
30-49	5533-5537	base	_
30-50	5538-5548	resolution	_
30-51	5549-5550	=	_
30-52	5551-5554	234	_
30-53	5555-5556	,	_
30-54	5557-5568	interleaved	_
30-55	5569-5580	acquisition	_
30-56	5581-5582	,	_
30-57	5583-5584	A	_
30-58	5585-5586	>	_
30-59	5587-5588	P	_
30-60	5589-5594	phase	_
30-61	5595-5601	encode	_
30-62	5602-5611	direction	_
30-63	5612-5613	,	_
30-64	5614-5615	1	_
30-65	5616-5618	ms	_
30-66	5619-5623	echo	_
30-67	5624-5631	spacing	_
30-68	5632-5633	,	_
30-69	5634-5637	gap	_
30-70	5638-5639	=	_
30-71	5640-5644	1.08	_
30-72	5645-5647	mm	_
30-73	5648-5649	)	_
30-74	5650-5651	.	_

Text=Six-minute resting-state scans consisted of 120 volumes.
31-1	5652-5662	Six-minute	_
31-2	5663-5676	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
31-3	5677-5682	scans	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
31-4	5683-5692	consisted	_
31-5	5693-5695	of	_
31-6	5696-5699	120	_
31-7	5700-5707	volumes	_
31-8	5708-5709	.	_

Text=Field maps were acquired using a gradient-recalled echo (GRE) sequence (TR/TE1/TE2 = 400/4.92/7.38 ms, 60° flip angle, 200 mm field of view, 36 slices, 3.1 mm × 3.1 mm × 3.0 mm voxels, base resolution = 64, interleaved acquisition, gap = 0.75 mm).
32-1	5710-5715	Field	_
32-2	5716-5720	maps	_
32-3	5721-5725	were	_
32-4	5726-5734	acquired	_
32-5	5735-5740	using	_
32-6	5741-5742	a	_
32-7	5743-5760	gradient-recalled	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
32-8	5761-5765	echo	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
32-9	5766-5767	(	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
32-10	5768-5771	GRE	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
32-11	5772-5773	)	http://maven.renci.org/NeuroBridge/neurobridge#Radiograph
32-12	5774-5782	sequence	_
32-13	5783-5784	(	_
32-14	5785-5795	TR/TE1/TE2	_
32-15	5796-5797	=	_
32-16	5798-5811	400/4.92/7.38	_
32-17	5812-5814	ms	_
32-18	5815-5816	,	_
32-19	5817-5820	60°	_
32-20	5821-5825	flip	_
32-21	5826-5831	angle	_
32-22	5832-5833	,	_
32-23	5834-5837	200	_
32-24	5838-5840	mm	_
32-25	5841-5846	field	_
32-26	5847-5849	of	_
32-27	5850-5854	view	_
32-28	5855-5856	,	_
32-29	5857-5859	36	_
32-30	5860-5866	slices	_
32-31	5867-5868	,	_
32-32	5869-5872	3.1	_
32-33	5873-5875	mm	_
32-34	5876-5877	×	_
32-35	5878-5881	3.1	_
32-36	5882-5884	mm	_
32-37	5885-5886	×	_
32-38	5887-5890	3.0	_
32-39	5891-5893	mm	_
32-40	5894-5900	voxels	_
32-41	5901-5902	,	_
32-42	5903-5907	base	_
32-43	5908-5918	resolution	_
32-44	5919-5920	=	_
32-45	5921-5923	64	_
32-46	5924-5925	,	_
32-47	5926-5937	interleaved	_
32-48	5938-5949	acquisition	_
32-49	5950-5951	,	_
32-50	5952-5955	gap	_
32-51	5956-5957	=	_
32-52	5958-5962	0.75	_
32-53	5963-5965	mm	_
32-54	5966-5967	)	_
32-55	5968-5969	.	_

Text=fMRI preprocessing Data preprocessing of resting-state scans was performed with SPM12 (Wellcome Trust Centre for Neuroimaging, London, UK; http: //www.fil.ion.ucl.ac.uk/spm/) and the “ CONN ” Connectivity Toolbox using standard preprocessing steps.
33-1	5970-5974	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
33-2	5975-5988	preprocessing	_
33-3	5989-5993	Data	_
33-4	5994-6007	preprocessing	_
33-5	6008-6010	of	_
33-6	6011-6024	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
33-7	6025-6030	scans	_
33-8	6031-6034	was	_
33-9	6035-6044	performed	_
33-10	6045-6049	with	_
33-11	6050-6055	SPM12	_
33-12	6056-6057	(	_
33-13	6058-6066	Wellcome	_
33-14	6067-6072	Trust	_
33-15	6073-6079	Centre	_
33-16	6080-6083	for	_
33-17	6084-6096	Neuroimaging	_
33-18	6097-6098	,	_
33-19	6099-6105	London	_
33-20	6106-6107	,	_
33-21	6108-6110	UK	_
33-22	6111-6112	;	_
33-23	6113-6117	http	_
33-24	6118-6119	:	_
33-25	6120-6148	//www.fil.ion.ucl.ac.uk/spm/	_
33-26	6149-6150	)	_
33-27	6151-6154	and	_
33-28	6155-6158	the	_
33-29	6159-6160	“	_
33-30	6161-6165	CONN	_
33-31	6166-6167	”	_
33-32	6168-6180	Connectivity	_
33-33	6181-6188	Toolbox	_
33-34	6189-6194	using	_
33-35	6195-6203	standard	_
33-36	6204-6217	preprocessing	_
33-37	6218-6223	steps	_
33-38	6224-6225	.	_

Text=More specifically, preprocessing steps included realignment and unwarping using phase maps, slice timing correction, coregistration to anatomical space using the T1-weighted MPRAGE structural image and using the first functional image as reference, normalization to Montreal Neurological Institute (MNI) space using the first functional volume as reference, artifact detection, and Gaussian smoothing [5 mm full-width half-maximum (FWHM)].
34-1	6226-6230	More	_
34-2	6231-6243	specifically	_
34-3	6244-6245	,	_
34-4	6246-6259	preprocessing	_
34-5	6260-6265	steps	_
34-6	6266-6274	included	_
34-7	6275-6286	realignment	_
34-8	6287-6290	and	_
34-9	6291-6300	unwarping	_
34-10	6301-6306	using	_
34-11	6307-6312	phase	_
34-12	6313-6317	maps	_
34-13	6318-6319	,	_
34-14	6320-6325	slice	_
34-15	6326-6332	timing	_
34-16	6333-6343	correction	_
34-17	6344-6345	,	_
34-18	6346-6360	coregistration	_
34-19	6361-6363	to	_
34-20	6364-6374	anatomical	_
34-21	6375-6380	space	_
34-22	6381-6386	using	_
34-23	6387-6390	the	_
34-24	6391-6402	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
34-25	6403-6409	MPRAGE	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
34-26	6410-6420	structural	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
34-27	6421-6426	image	_
34-28	6427-6430	and	_
34-29	6431-6436	using	_
34-30	6437-6440	the	_
34-31	6441-6446	first	_
34-32	6447-6457	functional	_
34-33	6458-6463	image	_
34-34	6464-6466	as	_
34-35	6467-6476	reference	_
34-36	6477-6478	,	_
34-37	6479-6492	normalization	_
34-38	6493-6495	to	_
34-39	6496-6504	Montreal	_
34-40	6505-6517	Neurological	_
34-41	6518-6527	Institute	_
34-42	6528-6529	(	_
34-43	6530-6533	MNI	_
34-44	6534-6535	)	_
34-45	6536-6541	space	_
34-46	6542-6547	using	_
34-47	6548-6551	the	_
34-48	6552-6557	first	_
34-49	6558-6568	functional	_
34-50	6569-6575	volume	_
34-51	6576-6578	as	_
34-52	6579-6588	reference	_
34-53	6589-6590	,	_
34-54	6591-6599	artifact	_
34-55	6600-6609	detection	_
34-56	6610-6611	,	_
34-57	6612-6615	and	_
34-58	6616-6624	Gaussian	_
34-59	6625-6634	smoothing	_
34-60	6635-6636	[	_
34-61	6637-6638	5	_
34-62	6639-6641	mm	_
34-63	6642-6652	full-width	_
34-64	6653-6665	half-maximum	_
34-65	6666-6667	(	_
34-66	6668-6672	FWHM	_
34-67	6673-6674	)	_
34-68	6675-6676	]	_
34-69	6677-6678	.	_

Text=Resulting preprocessed functional resting-state data maintained a spatial resolution of 0.855 mm × 0.855 mm × 2.88 mm.
35-1	6679-6688	Resulting	_
35-2	6689-6701	preprocessed	_
35-3	6702-6712	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
35-4	6713-6726	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
35-5	6727-6731	data	_
35-6	6732-6742	maintained	_
35-7	6743-6744	a	_
35-8	6745-6752	spatial	_
35-9	6753-6763	resolution	_
35-10	6764-6766	of	_
35-11	6767-6772	0.855	_
35-12	6773-6775	mm	_
35-13	6776-6777	×	_
35-14	6778-6783	0.855	_
35-15	6784-6786	mm	_
35-16	6787-6788	×	_
35-17	6789-6793	2.88	_
35-18	6794-6796	mm	_
35-19	6797-6798	.	_

Text=fMRI group independent component analysis The Group ICA of fMRI Toolbox (GIFT; http: //mialab.mrn.org/software/gift) was used to perform group-level spatial independent component analysis (ICA).
36-1	6799-6803	fMRI	_
36-2	6804-6809	group	_
36-3	6810-6821	independent	_
36-4	6822-6831	component	_
36-5	6832-6840	analysis	_
36-6	6841-6844	The	_
36-7	6845-6850	Group	_
36-8	6851-6854	ICA	_
36-9	6855-6857	of	_
36-10	6858-6862	fMRI	_
36-11	6863-6870	Toolbox	_
36-12	6871-6872	(	_
36-13	6873-6877	GIFT	_
36-14	6878-6879	;	_
36-15	6880-6884	http	_
36-16	6885-6886	:	_
36-17	6887-6917	//mialab.mrn.org/software/gift	_
36-18	6918-6919	)	_
36-19	6920-6923	was	_
36-20	6924-6928	used	_
36-21	6929-6931	to	_
36-22	6932-6939	perform	_
36-23	6940-6951	group-level	_
36-24	6952-6959	spatial	_
36-25	6960-6971	independent	_
36-26	6972-6981	component	_
36-27	6982-6990	analysis	_
36-28	6991-6992	(	_
36-29	6993-6996	ICA	_
36-30	6997-6998	)	_
36-31	6999-7000	.	_

Text=A subject-specific data reduction principal component analysis (PCA) first reduced the data to 75 principal components followed by a group data reduction retaining 50 principal components.
37-1	7001-7002	A	_
37-2	7003-7019	subject-specific	_
37-3	7020-7024	data	_
37-4	7025-7034	reduction	_
37-5	7035-7044	principal	_
37-6	7045-7054	component	_
37-7	7055-7063	analysis	_
37-8	7064-7065	(	_
37-9	7066-7069	PCA	_
37-10	7070-7071	)	_
37-11	7072-7077	first	_
37-12	7078-7085	reduced	_
37-13	7086-7089	the	_
37-14	7090-7094	data	_
37-15	7095-7097	to	_
37-16	7098-7100	75	_
37-17	7101-7110	principal	_
37-18	7111-7121	components	_
37-19	7122-7130	followed	_
37-20	7131-7133	by	_
37-21	7134-7135	a	_
37-22	7136-7141	group	_
37-23	7142-7146	data	_
37-24	7147-7156	reduction	_
37-25	7157-7166	retaining	_
37-26	7167-7169	50	_
37-27	7170-7179	principal	_
37-28	7180-7190	components	_
37-29	7191-7192	.	_

Text=In order to carry out PCA in a memory efficient-manner, PCA was carried out using the expectation maximization algorithm.
38-1	7193-7195	In	_
38-2	7196-7201	order	_
38-3	7202-7204	to	_
38-4	7205-7210	carry	_
38-5	7211-7214	out	_
38-6	7215-7218	PCA	_
38-7	7219-7221	in	_
38-8	7222-7223	a	_
38-9	7224-7230	memory	_
38-10	7231-7247	efficient-manner	_
38-11	7248-7249	,	_
38-12	7250-7253	PCA	_
38-13	7254-7257	was	_
38-14	7258-7265	carried	_
38-15	7266-7269	out	_
38-16	7270-7275	using	_
38-17	7276-7279	the	_
38-18	7280-7291	expectation	_
38-19	7292-7304	maximization	_
38-20	7305-7314	algorithm	_
38-21	7315-7316	.	_

Text=The infomax algorithm was then utilized for group-level spatial ICA to generate 50 spatially independent components (ICs) (See Supplementary Fig.
39-1	7317-7320	The	_
39-2	7321-7328	infomax	_
39-3	7329-7338	algorithm	_
39-4	7339-7342	was	_
39-5	7343-7347	then	_
39-6	7348-7356	utilized	_
39-7	7357-7360	for	_
39-8	7361-7372	group-level	_
39-9	7373-7380	spatial	_
39-10	7381-7384	ICA	_
39-11	7385-7387	to	_
39-12	7388-7396	generate	_
39-13	7397-7399	50	_
39-14	7400-7409	spatially	_
39-15	7410-7421	independent	_
39-16	7422-7432	components	_
39-17	7433-7434	(	_
39-18	7435-7438	ICs	_
39-19	7439-7440	)	_
39-20	7441-7442	(	_
39-21	7443-7446	See	_
39-22	7447-7460	Supplementary	_
39-23	7461-7464	Fig	_
39-24	7465-7466	.	_

Text=1 for estimation of the number of ICs using minimum description length criteria).
40-1	7467-7468	1	_
40-2	7469-7472	for	_
40-3	7473-7483	estimation	_
40-4	7484-7486	of	_
40-5	7487-7490	the	_
40-6	7491-7497	number	_
40-7	7498-7500	of	_
40-8	7501-7504	ICs	_
40-9	7505-7510	using	_
40-10	7511-7518	minimum	_
40-11	7519-7530	description	_
40-12	7531-7537	length	_
40-13	7538-7546	criteria	_
40-14	7547-7548	)	_
40-15	7549-7550	.	_

Text=In order to measure component stability/quality, the infomax ICA algorithm was repeated 20 times in ICASSO and the most representative run was used in subsequent steps.
41-1	7551-7553	In	_
41-2	7554-7559	order	_
41-3	7560-7562	to	_
41-4	7563-7570	measure	_
41-5	7571-7580	component	_
41-6	7581-7598	stability/quality	_
41-7	7599-7600	,	_
41-8	7601-7604	the	_
41-9	7605-7612	infomax	_
41-10	7613-7616	ICA	_
41-11	7617-7626	algorithm	_
41-12	7627-7630	was	_
41-13	7631-7639	repeated	_
41-14	7640-7642	20	_
41-15	7643-7648	times	_
41-16	7649-7651	in	_
41-17	7652-7658	ICASSO	_
41-18	7659-7662	and	_
41-19	7663-7666	the	_
41-20	7667-7671	most	_
41-21	7672-7686	representative	_
41-22	7687-7690	run	_
41-23	7691-7694	was	_
41-24	7695-7699	used	_
41-25	7700-7702	in	_
41-26	7703-7713	subsequent	_
41-27	7714-7719	steps	_
41-28	7720-7721	.	_

Text=Subject-specific spatial maps and time courses were estimated using GICA back-reconstruction.
42-1	7722-7738	Subject-specific	_
42-2	7739-7746	spatial	_
42-3	7747-7751	maps	_
42-4	7752-7755	and	_
42-5	7756-7760	time	_
42-6	7761-7768	courses	_
42-7	7769-7773	were	_
42-8	7774-7783	estimated	_
42-9	7784-7789	using	_
42-10	7790-7794	GICA	_
42-11	7795-7814	back-reconstruction	_
42-12	7815-7816	.	_

Text=fMRI component identification In accordance with previous studies, ICs were classified as resting-state networks (RSNs), rather than artifacts, based on spectral properties and functional relevance.
43-1	7817-7821	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
43-2	7822-7831	component	_
43-3	7832-7846	identification	_
43-4	7847-7849	In	_
43-5	7850-7860	accordance	_
43-6	7861-7865	with	_
43-7	7866-7874	previous	_
43-8	7875-7882	studies	_
43-9	7883-7884	,	_
43-10	7885-7888	ICs	_
43-11	7889-7893	were	_
43-12	7894-7904	classified	_
43-13	7905-7907	as	_
43-14	7908-7921	resting-state	_
43-15	7922-7930	networks	_
43-16	7931-7932	(	_
43-17	7933-7937	RSNs	_
43-18	7938-7939	)	_
43-19	7940-7941	,	_
43-20	7942-7948	rather	_
43-21	7949-7953	than	_
43-22	7954-7963	artifacts	_
43-23	7964-7965	,	_
43-24	7966-7971	based	_
43-25	7972-7974	on	_
43-26	7975-7983	spectral	_
43-27	7984-7994	properties	_
43-28	7995-7998	and	_
43-29	7999-8009	functional	_
43-30	8010-8019	relevance	_
43-31	8020-8021	.	_

Text=The power spectra for each component were characterized by dynamic range and the ratio of low frequency to high frequency power.
44-1	8022-8025	The	_
44-2	8026-8031	power	_
44-3	8032-8039	spectra	_
44-4	8040-8043	for	_
44-5	8044-8048	each	_
44-6	8049-8058	component	_
44-7	8059-8063	were	_
44-8	8064-8077	characterized	_
44-9	8078-8080	by	_
44-10	8081-8088	dynamic	_
44-11	8089-8094	range	_
44-12	8095-8098	and	_
44-13	8099-8102	the	_
44-14	8103-8108	ratio	_
44-15	8109-8111	of	_
44-16	8112-8115	low	_
44-17	8116-8125	frequency	_
44-18	8126-8128	to	_
44-19	8129-8133	high	_
44-20	8134-8143	frequency	_
44-21	8144-8149	power	_
44-22	8150-8151	.	_

Text=Dynamic range can be defined as the difference between maximum power and minimum power at frequencies to the right of the power spectra peak.
45-1	8152-8159	Dynamic	_
45-2	8160-8165	range	_
45-3	8166-8169	can	_
45-4	8170-8172	be	_
45-5	8173-8180	defined	_
45-6	8181-8183	as	_
45-7	8184-8187	the	_
45-8	8188-8198	difference	_
45-9	8199-8206	between	_
45-10	8207-8214	maximum	_
45-11	8215-8220	power	_
45-12	8221-8224	and	_
45-13	8225-8232	minimum	_
45-14	8233-8238	power	_
45-15	8239-8241	at	_
45-16	8242-8253	frequencies	_
45-17	8254-8256	to	_
45-18	8257-8260	the	_
45-19	8261-8266	right	_
45-20	8267-8269	of	_
45-21	8270-8273	the	_
45-22	8274-8279	power	_
45-23	8280-8287	spectra	_
45-24	8288-8292	peak	_
45-25	8293-8294	.	_

Text=The ratio of low frequency to high frequency power can be defined as the ratio of integral spectral power below 0.1 Hz to integral spectral power between 0.15 and 0.167 Hz.
46-1	8295-8298	The	_
46-2	8299-8304	ratio	_
46-3	8305-8307	of	_
46-4	8308-8311	low	_
46-5	8312-8321	frequency	_
46-6	8322-8324	to	_
46-7	8325-8329	high	_
46-8	8330-8339	frequency	_
46-9	8340-8345	power	_
46-10	8346-8349	can	_
46-11	8350-8352	be	_
46-12	8353-8360	defined	_
46-13	8361-8363	as	_
46-14	8364-8367	the	_
46-15	8368-8373	ratio	_
46-16	8374-8376	of	_
46-17	8377-8385	integral	_
46-18	8386-8394	spectral	_
46-19	8395-8400	power	_
46-20	8401-8406	below	_
46-21	8407-8410	0.1	_
46-22	8411-8413	Hz	_
46-23	8414-8416	to	_
46-24	8417-8425	integral	_
46-25	8426-8434	spectral	_
46-26	8435-8440	power	_
46-27	8441-8448	between	_
46-28	8449-8453	0.15	_
46-29	8454-8457	and	_
46-30	8458-8463	0.167	_
46-31	8464-8466	Hz	_
46-32	8467-8468	.	_

Text=Components were also evaluated for functional relevance via visual inspection.
47-1	8469-8479	Components	_
47-2	8480-8484	were	_
47-3	8485-8489	also	_
47-4	8490-8499	evaluated	_
47-5	8500-8503	for	_
47-6	8504-8514	functional	_
47-7	8515-8524	relevance	_
47-8	8525-8528	via	_
47-9	8529-8535	visual	_
47-10	8536-8546	inspection	_
47-11	8547-8548	.	_

Text=Components were inspected and classified as non-artifactual or RSNs based on the following criteria: (1) peak activations should occur primarily in grey matter and correspond anatomically to known functional brain networks, (2) low spatial overlap with vascular, ventricular, motion and susceptibility artifacts, (3) time courses predominantly characterized by low frequency fluctuations.
48-1	8549-8559	Components	_
48-2	8560-8564	were	_
48-3	8565-8574	inspected	_
48-4	8575-8578	and	_
48-5	8579-8589	classified	_
48-6	8590-8592	as	_
48-7	8593-8608	non-artifactual	_
48-8	8609-8611	or	_
48-9	8612-8616	RSNs	_
48-10	8617-8622	based	_
48-11	8623-8625	on	_
48-12	8626-8629	the	_
48-13	8630-8639	following	_
48-14	8640-8648	criteria	_
48-15	8649-8650	:	_
48-16	8651-8652	(	_
48-17	8653-8654	1	_
48-18	8655-8656	)	_
48-19	8657-8661	peak	_
48-20	8662-8673	activations	_
48-21	8674-8680	should	_
48-22	8681-8686	occur	_
48-23	8687-8696	primarily	_
48-24	8697-8699	in	_
48-25	8700-8704	grey	_
48-26	8705-8711	matter	_
48-27	8712-8715	and	_
48-28	8716-8726	correspond	_
48-29	8727-8739	anatomically	_
48-30	8740-8742	to	_
48-31	8743-8748	known	_
48-32	8749-8759	functional	_
48-33	8760-8765	brain	_
48-34	8766-8774	networks	_
48-35	8775-8776	,	_
48-36	8777-8778	(	_
48-37	8779-8780	2	_
48-38	8781-8782	)	_
48-39	8783-8786	low	_
48-40	8787-8794	spatial	_
48-41	8795-8802	overlap	_
48-42	8803-8807	with	_
48-43	8808-8816	vascular	_
48-44	8817-8818	,	_
48-45	8819-8830	ventricular	_
48-46	8831-8832	,	_
48-47	8833-8839	motion	_
48-48	8840-8843	and	_
48-49	8844-8858	susceptibility	_
48-50	8859-8868	artifacts	_
48-51	8869-8870	,	_
48-52	8871-8872	(	_
48-53	8873-8874	3	_
48-54	8875-8876	)	_
48-55	8877-8881	time	_
48-56	8882-8889	courses	_
48-57	8890-8903	predominantly	_
48-58	8904-8917	characterized	_
48-59	8918-8920	by	_
48-60	8921-8924	low	_
48-61	8925-8934	frequency	_
48-62	8935-8947	fluctuations	_
48-63	8948-8949	.	_

Text=Of the 50 components extracted, 30 were identified as RSNs (Fig.
49-1	8950-8952	Of	_
49-2	8953-8956	the	_
49-3	8957-8959	50	_
49-4	8960-8970	components	_
49-5	8971-8980	extracted	_
49-6	8981-8982	,	_
49-7	8983-8985	30	_
49-8	8986-8990	were	_
49-9	8991-9001	identified	_
49-10	9002-9004	as	_
49-11	9005-9009	RSNs	_
49-12	9010-9011	(	_
49-13	9012-9015	Fig	_
49-14	9016-9017	.	_

Text=1).
50-1	9018-9019	1	_
50-2	9020-9021	)	_
50-3	9022-9023	.	_

Text=MEG analysis MEG scanning parameters Resting-state MEG recordings were collected in a shielded room below ground level using a 148-channel whole head magnetometer (MagnesTM 2500 WH, 4-D Neuroimaging) at the University of Alabama at Birmingham.
51-1	9024-9027	MEG	_
51-2	9028-9036	analysis	_
51-3	9037-9040	MEG	_
51-4	9041-9049	scanning	_
51-5	9050-9060	parameters	_
51-6	9061-9074	Resting-state	_
51-7	9075-9078	MEG	_
51-8	9079-9089	recordings	_
51-9	9090-9094	were	_
51-10	9095-9104	collected	_
51-11	9105-9107	in	_
51-12	9108-9109	a	_
51-13	9110-9118	shielded	_
51-14	9119-9123	room	_
51-15	9124-9129	below	_
51-16	9130-9136	ground	_
51-17	9137-9142	level	_
51-18	9143-9148	using	_
51-19	9149-9150	a	_
51-20	9151-9162	148-channel	_
51-21	9163-9168	whole	_
51-22	9169-9173	head	_
51-23	9174-9186	magnetometer	_
51-24	9187-9188	(	_
51-25	9189-9197	MagnesTM	_
51-26	9198-9202	2500	_
51-27	9203-9205	WH	_
51-28	9206-9207	,	_
51-29	9208-9211	4-D	_
51-30	9212-9224	Neuroimaging	_
51-31	9225-9226	)	_
51-32	9227-9229	at	_
51-33	9230-9233	the	_
51-34	9234-9244	University	_
51-35	9245-9247	of	_
51-36	9248-9255	Alabama	_
51-37	9256-9258	at	_
51-38	9259-9269	Birmingham	_
51-39	9270-9271	.	_

Text=Recordings were sampled at a rate of 1000 Hz, with a bandpass filter of 0.1 to 200 Hz.
52-1	9272-9282	Recordings	_
52-2	9283-9287	were	_
52-3	9288-9295	sampled	_
52-4	9296-9298	at	_
52-5	9299-9300	a	_
52-6	9301-9305	rate	_
52-7	9306-9308	of	_
52-8	9309-9313	1000	_
52-9	9314-9316	Hz	_
52-10	9317-9318	,	_
52-11	9319-9323	with	_
52-12	9324-9325	a	_
52-13	9326-9334	bandpass	_
52-14	9335-9341	filter	_
52-15	9342-9344	of	_
52-16	9345-9348	0.1	_
52-17	9349-9351	to	_
52-18	9352-9355	200	_
52-19	9356-9358	Hz	_
52-20	9359-9360	.	_

Text=Fiducial head-sensor coils were used to ensure the subject's head did not move during a scan.
53-1	9361-9369	Fiducial	_
53-2	9370-9381	head-sensor	_
53-3	9382-9387	coils	_
53-4	9388-9392	were	_
53-5	9393-9397	used	_
53-6	9398-9400	to	_
53-7	9401-9407	ensure	_
53-8	9408-9411	the	_
53-9	9412-9419	subject	_
53-10	9420-9422	's	_
53-11	9423-9427	head	_
53-12	9428-9431	did	_
53-13	9432-9435	not	_
53-14	9436-9440	move	_
53-15	9441-9447	during	_
53-16	9448-9449	a	_
53-17	9450-9454	scan	_
53-18	9455-9456	.	_

Text=Additional head-sensor data were collected using a 3D digitizer and later used for registration between each subject's MEG and anatomical MRI.
54-1	9457-9467	Additional	_
54-2	9468-9479	head-sensor	_
54-3	9480-9484	data	_
54-4	9485-9489	were	_
54-5	9490-9499	collected	_
54-6	9500-9505	using	_
54-7	9506-9507	a	_
54-8	9508-9510	3D	_
54-9	9511-9520	digitizer	_
54-10	9521-9524	and	_
54-11	9525-9530	later	_
54-12	9531-9535	used	_
54-13	9536-9539	for	_
54-14	9540-9552	registration	_
54-15	9553-9560	between	_
54-16	9561-9565	each	_
54-17	9566-9573	subject	_
54-18	9574-9576	's	_
54-19	9577-9580	MEG	_
54-20	9581-9584	and	_
54-21	9585-9595	anatomical	_
54-22	9596-9599	MRI	_
54-23	9600-9601	.	_

Text=During the 5-min resting-state scan, subjects were placed in the supine position with eyes closed.
55-1	9602-9608	During	_
55-2	9609-9612	the	_
55-3	9613-9618	5-min	_
55-4	9619-9632	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
55-5	9633-9637	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
55-6	9638-9639	,	_
55-7	9640-9648	subjects	_
55-8	9649-9653	were	_
55-9	9654-9660	placed	_
55-10	9661-9663	in	_
55-11	9664-9667	the	_
55-12	9668-9674	supine	_
55-13	9675-9683	position	_
55-14	9684-9688	with	_
55-15	9689-9693	eyes	_
55-16	9694-9700	closed	_
55-17	9701-9702	.	_

Text=Visual inspection of the real-time display showed no MEG correlates of sleep.
56-1	9703-9709	Visual	_
56-2	9710-9720	inspection	_
56-3	9721-9723	of	_
56-4	9724-9727	the	_
56-5	9728-9737	real-time	_
56-6	9738-9745	display	_
56-7	9746-9752	showed	_
56-8	9753-9755	no	_
56-9	9756-9759	MEG	_
56-10	9760-9770	correlates	_
56-11	9771-9773	of	_
56-12	9774-9779	sleep	_
56-13	9780-9781	.	_

Text=Subjects were also clearly responsive immediately before and after the scanning period as they all instantly opened their eyes upon instruction.
57-1	9782-9790	Subjects	_
57-2	9791-9795	were	_
57-3	9796-9800	also	_
57-4	9801-9808	clearly	_
57-5	9809-9819	responsive	_
57-6	9820-9831	immediately	_
57-7	9832-9838	before	_
57-8	9839-9842	and	_
57-9	9843-9848	after	_
57-10	9849-9852	the	_
57-11	9853-9861	scanning	_
57-12	9862-9868	period	_
57-13	9869-9871	as	_
57-14	9872-9876	they	_
57-15	9877-9880	all	_
57-16	9881-9890	instantly	_
57-17	9891-9897	opened	_
57-18	9898-9903	their	_
57-19	9904-9908	eyes	_
57-20	9909-9913	upon	_
57-21	9914-9925	instruction	_
57-22	9926-9927	.	_

Text=MEG preprocessing MEG data were analyzed using Brainstorm.
58-1	9928-9931	MEG	_
58-2	9932-9945	preprocessing	_
58-3	9946-9949	MEG	_
58-4	9950-9954	data	_
58-5	9955-9959	were	_
58-6	9960-9968	analyzed	_
58-7	9969-9974	using	_
58-8	9975-9985	Brainstorm	_
58-9	9986-9987	.	_

Text=Preprocessing of the raw data included removal of line noise data using a notch filter (60, 120, 180, 240, 300 Hz) and high-pass filtering at 0.3 Hz.
59-1	9988-10001	Preprocessing	_
59-2	10002-10004	of	_
59-3	10005-10008	the	_
59-4	10009-10012	raw	_
59-5	10013-10017	data	_
59-6	10018-10026	included	_
59-7	10027-10034	removal	_
59-8	10035-10037	of	_
59-9	10038-10042	line	_
59-10	10043-10048	noise	_
59-11	10049-10053	data	_
59-12	10054-10059	using	_
59-13	10060-10061	a	_
59-14	10062-10067	notch	_
59-15	10068-10074	filter	_
59-16	10075-10076	(	_
59-17	10077-10079	60	_
59-18	10080-10081	,	_
59-19	10082-10085	120	_
59-20	10086-10087	,	_
59-21	10088-10091	180	_
59-22	10092-10093	,	_
59-23	10094-10097	240	_
59-24	10098-10099	,	_
59-25	10100-10103	300	_
59-26	10104-10106	Hz	_
59-27	10107-10108	)	_
59-28	10109-10112	and	_
59-29	10113-10122	high-pass	_
59-30	10123-10132	filtering	_
59-31	10133-10135	at	_
59-32	10136-10139	0.3	_
59-33	10140-10142	Hz	_
59-34	10143-10144	.	_

Text=Cardiac and motion artifact was removed from the signal using an independent component analysis where the signal was decomposed into 20 independent components using JADE (joint approximate diagonalization of eigenmatrices).
60-1	10145-10152	Cardiac	_
60-2	10153-10156	and	_
60-3	10157-10163	motion	_
60-4	10164-10172	artifact	_
60-5	10173-10176	was	_
60-6	10177-10184	removed	_
60-7	10185-10189	from	_
60-8	10190-10193	the	_
60-9	10194-10200	signal	_
60-10	10201-10206	using	_
60-11	10207-10209	an	_
60-12	10210-10221	independent	_
60-13	10222-10231	component	_
60-14	10232-10240	analysis	_
60-15	10241-10246	where	_
60-16	10247-10250	the	_
60-17	10251-10257	signal	_
60-18	10258-10261	was	_
60-19	10262-10272	decomposed	_
60-20	10273-10277	into	_
60-21	10278-10280	20	_
60-22	10281-10292	independent	_
60-23	10293-10303	components	_
60-24	10304-10309	using	_
60-25	10310-10314	JADE	_
60-26	10315-10316	(	_
60-27	10317-10322	joint	_
60-28	10323-10334	approximate	_
60-29	10335-10350	diagonalization	_
60-30	10351-10353	of	_
60-31	10354-10367	eigenmatrices	_
60-32	10368-10369	)	_
60-33	10370-10371	.	_

Text=Additional artifacts were removed using a signal-space projection method.
61-1	10372-10382	Additional	_
61-2	10383-10392	artifacts	_
61-3	10393-10397	were	_
61-4	10398-10405	removed	_
61-5	10406-10411	using	_
61-6	10412-10413	a	_
61-7	10414-10426	signal-space	_
61-8	10427-10437	projection	_
61-9	10438-10444	method	_
61-10	10445-10446	.	_

Text=Resting-state MEG data was then registered to individual subject high resolution structural MRI scans.
62-1	10447-10460	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
62-2	10461-10464	MEG	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
62-3	10465-10469	data	_
62-4	10470-10473	was	_
62-5	10474-10478	then	_
62-6	10479-10489	registered	_
62-7	10490-10492	to	_
62-8	10493-10503	individual	_
62-9	10504-10511	subject	_
62-10	10512-10516	high	_
62-11	10517-10527	resolution	_
62-12	10528-10538	structural	_
62-13	10539-10542	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
62-14	10543-10548	scans	_
62-15	10549-10550	.	_

Text=Prior to MEG-MRI registration, cortical surfaces and subcortical structures from each structural MRI were extracted using the FreeSurfer image analysis suite (http: //surfer.nmr.mgh.harvard.edu/) and subsequently inspected using FreeSurfer's QA Tools.
63-1	10551-10556	Prior	_
63-2	10557-10559	to	_
63-3	10560-10567	MEG-MRI	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
63-4	10568-10580	registration	_
63-5	10581-10582	,	_
63-6	10583-10591	cortical	_
63-7	10592-10600	surfaces	_
63-8	10601-10604	and	_
63-9	10605-10616	subcortical	_
63-10	10617-10627	structures	_
63-11	10628-10632	from	_
63-12	10633-10637	each	_
63-13	10638-10648	structural	_
63-14	10649-10652	MRI	_
63-15	10653-10657	were	_
63-16	10658-10667	extracted	_
63-17	10668-10673	using	_
63-18	10674-10677	the	_
63-19	10678-10688	FreeSurfer	_
63-20	10689-10694	image	_
63-21	10695-10703	analysis	_
63-22	10704-10709	suite	_
63-23	10710-10711	(	_
63-24	10712-10716	http	_
63-25	10717-10718	:	_
63-26	10719-10748	//surfer.nmr.mgh.harvard.edu/	_
63-27	10749-10750	)	_
63-28	10751-10754	and	_
63-29	10755-10767	subsequently	_
63-30	10768-10777	inspected	_
63-31	10778-10783	using	_
63-32	10784-10794	FreeSurfer	_
63-33	10795-10797	's	_
63-34	10798-10800	QA	_
63-35	10801-10806	Tools	_
63-36	10807-10808	.	_

Text=Data identified as unsatisfactory during quality assurance were manually corrected and reprocessed.
64-1	10809-10813	Data	_
64-2	10814-10824	identified	_
64-3	10825-10827	as	_
64-4	10828-10842	unsatisfactory	_
64-5	10843-10849	during	_
64-6	10850-10857	quality	_
64-7	10858-10867	assurance	_
64-8	10868-10872	were	_
64-9	10873-10881	manually	_
64-10	10882-10891	corrected	_
64-11	10892-10895	and	_
64-12	10896-10907	reprocessed	_
64-13	10908-10909	.	_

Text=A pseudo-individual anatomy for each subject missing structural MRI scans (n = 5) was created by warping the default ICBM 152 template anatomy in Brainstorm to the digitized head points.
65-1	10910-10911	A	_
65-2	10912-10929	pseudo-individual	_
65-3	10930-10937	anatomy	_
65-4	10938-10941	for	_
65-5	10942-10946	each	_
65-6	10947-10954	subject	_
65-7	10955-10962	missing	_
65-8	10963-10973	structural	_
65-9	10974-10977	MRI	_
65-10	10978-10983	scans	_
65-11	10984-10985	(	_
65-12	10986-10987	n	_
65-13	10988-10989	=	_
65-14	10990-10991	5	_
65-15	10992-10993	)	_
65-16	10994-10997	was	_
65-17	10998-11005	created	_
65-18	11006-11008	by	_
65-19	11009-11016	warping	_
65-20	11017-11020	the	_
65-21	11021-11028	default	_
65-22	11029-11033	ICBM	_
65-23	11034-11037	152	_
65-24	11038-11046	template	_
65-25	11047-11054	anatomy	_
65-26	11055-11057	in	_
65-27	11058-11068	Brainstorm	_
65-28	11069-11071	to	_
65-29	11072-11075	the	_
65-30	11076-11085	digitized	_
65-31	11086-11090	head	_
65-32	11091-11097	points	_
65-33	11098-11099	.	_

Text=A 15,000-vertex cortical surface source model was used for head modeling.
66-1	11100-11101	A	_
66-2	11102-11115	15,000-vertex	_
66-3	11116-11124	cortical	_
66-4	11125-11132	surface	_
66-5	11133-11139	source	_
66-6	11140-11145	model	_
66-7	11146-11149	was	_
66-8	11150-11154	used	_
66-9	11155-11158	for	_
66-10	11159-11163	head	_
66-11	11164-11172	modeling	_
66-12	11173-11174	.	_

Text=Forward volume head modeling of the magnetic field was defined using an overlapping-sphere method where voxels were placed on a 5 mm3 grid of the brain.
67-1	11175-11182	Forward	_
67-2	11183-11189	volume	_
67-3	11190-11194	head	_
67-4	11195-11203	modeling	_
67-5	11204-11206	of	_
67-6	11207-11210	the	_
67-7	11211-11219	magnetic	_
67-8	11220-11225	field	_
67-9	11226-11229	was	_
67-10	11230-11237	defined	_
67-11	11238-11243	using	_
67-12	11244-11246	an	_
67-13	11247-11265	overlapping-sphere	_
67-14	11266-11272	method	_
67-15	11273-11278	where	_
67-16	11279-11285	voxels	_
67-17	11286-11290	were	_
67-18	11291-11297	placed	_
67-19	11298-11300	on	_
67-20	11301-11302	a	_
67-21	11303-11304	5	_
67-22	11305-11308	mm3	_
67-23	11309-11313	grid	_
67-24	11314-11316	of	_
67-25	11317-11320	the	_
67-26	11321-11326	brain	_
67-27	11327-11328	.	_

Text=Inverse source modeling was performed using a linearly-constrained minimum variance (LCMV) beamformer.
68-1	11329-11336	Inverse	_
68-2	11337-11343	source	_
68-3	11344-11352	modeling	_
68-4	11353-11356	was	_
68-5	11357-11366	performed	_
68-6	11367-11372	using	_
68-7	11373-11374	a	_
68-8	11375-11395	linearly-constrained	_
68-9	11396-11403	minimum	_
68-10	11404-11412	variance	_
68-11	11413-11414	(	_
68-12	11415-11419	LCMV	_
68-13	11420-11421	)	_
68-14	11422-11432	beamformer	_
68-15	11433-11434	.	_

Text=Beamformer projection was performed using an unconstrained dipole orientation for each subject separately.
69-1	11435-11445	Beamformer	_
69-2	11446-11456	projection	_
69-3	11457-11460	was	_
69-4	11461-11470	performed	_
69-5	11471-11476	using	_
69-6	11477-11479	an	_
69-7	11480-11493	unconstrained	_
69-8	11494-11500	dipole	_
69-9	11501-11512	orientation	_
69-10	11513-11516	for	_
69-11	11517-11521	each	_
69-12	11522-11529	subject	_
69-13	11530-11540	separately	_
69-14	11541-11542	.	_

Text=Data covariance matrices generated for each subject were regularized using a median eigenvalue approach where the tail of the eigenvalues spectrum is flattened to the median value.
70-1	11543-11547	Data	_
70-2	11548-11558	covariance	_
70-3	11559-11567	matrices	_
70-4	11568-11577	generated	_
70-5	11578-11581	for	_
70-6	11582-11586	each	_
70-7	11587-11594	subject	_
70-8	11595-11599	were	_
70-9	11600-11611	regularized	_
70-10	11612-11617	using	_
70-11	11618-11619	a	_
70-12	11620-11626	median	_
70-13	11627-11637	eigenvalue	_
70-14	11638-11646	approach	_
70-15	11647-11652	where	_
70-16	11653-11656	the	_
70-17	11657-11661	tail	_
70-18	11662-11664	of	_
70-19	11665-11668	the	_
70-20	11669-11680	eigenvalues	_
70-21	11681-11689	spectrum	_
70-22	11690-11692	is	_
70-23	11693-11702	flattened	_
70-24	11703-11705	to	_
70-25	11706-11709	the	_
70-26	11710-11716	median	_
70-27	11717-11722	value	_
70-28	11723-11724	.	_

Text=MEG Hilbert envelope computation The Hilbert transform was applied to the resting-state time courses in which the signals were first filtered into delta (1–4 Hz), theta (4–8 Hz), alpha (8–13 Hz), beta (13–30 Hz), and gamma (30–50 Hz) frequency bands using a band-pass filter followed by application of the Hilbert transform.
71-1	11725-11728	MEG	_
71-2	11729-11736	Hilbert	_
71-3	11737-11745	envelope	_
71-4	11746-11757	computation	_
71-5	11758-11761	The	_
71-6	11762-11769	Hilbert	_
71-7	11770-11779	transform	_
71-8	11780-11783	was	_
71-9	11784-11791	applied	_
71-10	11792-11794	to	_
71-11	11795-11798	the	_
71-12	11799-11812	resting-state	_
71-13	11813-11817	time	_
71-14	11818-11825	courses	_
71-15	11826-11828	in	_
71-16	11829-11834	which	_
71-17	11835-11838	the	_
71-18	11839-11846	signals	_
71-19	11847-11851	were	_
71-20	11852-11857	first	_
71-21	11858-11866	filtered	_
71-22	11867-11871	into	_
71-23	11872-11877	delta	_
71-24	11878-11879	(	_
71-25	11880-11883	1–4	_
71-26	11884-11886	Hz	_
71-27	11887-11888	)	_
71-28	11889-11890	,	_
71-29	11891-11896	theta	_
71-30	11897-11898	(	_
71-31	11899-11902	4–8	_
71-32	11903-11905	Hz	_
71-33	11906-11907	)	_
71-34	11908-11909	,	_
71-35	11910-11915	alpha	_
71-36	11916-11917	(	_
71-37	11918-11922	8–13	_
71-38	11923-11925	Hz	_
71-39	11926-11927	)	_
71-40	11928-11929	,	_
71-41	11930-11934	beta	_
71-42	11935-11936	(	_
71-43	11937-11942	13–30	_
71-44	11943-11945	Hz	_
71-45	11946-11947	)	_
71-46	11948-11949	,	_
71-47	11950-11953	and	_
71-48	11954-11959	gamma	_
71-49	11960-11961	(	_
71-50	11962-11967	30–50	_
71-51	11968-11970	Hz	_
71-52	11971-11972	)	_
71-53	11973-11982	frequency	_
71-54	11983-11988	bands	_
71-55	11989-11994	using	_
71-56	11995-11996	a	_
71-57	11997-12006	band-pass	_
71-58	12007-12013	filter	_
71-59	12014-12022	followed	_
71-60	12023-12025	by	_
71-61	12026-12037	application	_
71-62	12038-12040	of	_
71-63	12041-12044	the	_
71-64	12045-12052	Hilbert	_
71-65	12053-12062	transform	_
71-66	12063-12064	.	_

Text=The absolute value of the transformed signals was subsequently computed in order to provide a measure of the envelope of the signal.
72-1	12065-12068	The	_
72-2	12069-12077	absolute	_
72-3	12078-12083	value	_
72-4	12084-12086	of	_
72-5	12087-12090	the	_
72-6	12091-12102	transformed	_
72-7	12103-12110	signals	_
72-8	12111-12114	was	_
72-9	12115-12127	subsequently	_
72-10	12128-12136	computed	_
72-11	12137-12139	in	_
72-12	12140-12145	order	_
72-13	12146-12148	to	_
72-14	12149-12156	provide	_
72-15	12157-12158	a	_
72-16	12159-12166	measure	_
72-17	12167-12169	of	_
72-18	12170-12173	the	_
72-19	12174-12182	envelope	_
72-20	12183-12185	of	_
72-21	12186-12189	the	_
72-22	12190-12196	signal	_
72-23	12197-12198	.	_

Text=The Hilbert envelope values were then standardized using a 1/frequency compensation where values at each frequency bin were multiplied by the frequency value.
73-1	12199-12202	The	_
73-2	12203-12210	Hilbert	_
73-3	12211-12219	envelope	_
73-4	12220-12226	values	_
73-5	12227-12231	were	_
73-6	12232-12236	then	_
73-7	12237-12249	standardized	_
73-8	12250-12255	using	_
73-9	12256-12257	a	_
73-10	12258-12269	1/frequency	_
73-11	12270-12282	compensation	_
73-12	12283-12288	where	_
73-13	12289-12295	values	_
73-14	12296-12298	at	_
73-15	12299-12303	each	_
73-16	12304-12313	frequency	_
73-17	12314-12317	bin	_
73-18	12318-12322	were	_
73-19	12323-12333	multiplied	_
73-20	12334-12336	by	_
73-21	12337-12340	the	_
73-22	12341-12350	frequency	_
73-23	12351-12356	value	_
73-24	12357-12358	.	_

Text=Following spectrum normalization, the Hilbert envelope was downsampled to 1 Hz in accordance with previous studies.
74-1	12359-12368	Following	_
74-2	12369-12377	spectrum	_
74-3	12378-12391	normalization	_
74-4	12392-12393	,	_
74-5	12394-12397	the	_
74-6	12398-12405	Hilbert	_
74-7	12406-12414	envelope	_
74-8	12415-12418	was	_
74-9	12419-12430	downsampled	_
74-10	12431-12433	to	_
74-11	12434-12435	1	_
74-12	12436-12438	Hz	_
74-13	12439-12441	in	_
74-14	12442-12452	accordance	_
74-15	12453-12457	with	_
74-16	12458-12466	previous	_
74-17	12467-12474	studies	_
74-18	12475-12476	.	_

Text=Therefore, scans consisted of 301 volumes for each frequency band.
75-1	12477-12486	Therefore	_
75-2	12487-12488	,	_
75-3	12489-12494	scans	_
75-4	12495-12504	consisted	_
75-5	12505-12507	of	_
75-6	12508-12511	301	_
75-7	12512-12519	volumes	_
75-8	12520-12523	for	_
75-9	12524-12528	each	_
75-10	12529-12538	frequency	_
75-11	12539-12543	band	_
75-12	12544-12545	.	_

Text=In order to enable comparison between subjects and groups, downsampled source envelope data for each subject were spatially interpolated from the individual subject head model to the MNI ICBM 152 default MRI template in Brainstorm and spatially smoothed (5 mm FWHM).
76-1	12546-12548	In	_
76-2	12549-12554	order	_
76-3	12555-12557	to	_
76-4	12558-12564	enable	_
76-5	12565-12575	comparison	_
76-6	12576-12583	between	_
76-7	12584-12592	subjects	_
76-8	12593-12596	and	_
76-9	12597-12603	groups	_
76-10	12604-12605	,	_
76-11	12606-12617	downsampled	_
76-12	12618-12624	source	_
76-13	12625-12633	envelope	_
76-14	12634-12638	data	_
76-15	12639-12642	for	_
76-16	12643-12647	each	_
76-17	12648-12655	subject	_
76-18	12656-12660	were	_
76-19	12661-12670	spatially	_
76-20	12671-12683	interpolated	_
76-21	12684-12688	from	_
76-22	12689-12692	the	_
76-23	12693-12703	individual	_
76-24	12704-12711	subject	_
76-25	12712-12716	head	_
76-26	12717-12722	model	_
76-27	12723-12725	to	_
76-28	12726-12729	the	_
76-29	12730-12733	MNI	_
76-30	12734-12738	ICBM	_
76-31	12739-12742	152	_
76-32	12743-12750	default	_
76-33	12751-12754	MRI	_
76-34	12755-12763	template	_
76-35	12764-12766	in	_
76-36	12767-12777	Brainstorm	_
76-37	12778-12781	and	_
76-38	12782-12791	spatially	_
76-39	12792-12800	smoothed	_
76-40	12801-12802	(	_
76-41	12803-12804	5	_
76-42	12805-12807	mm	_
76-43	12808-12812	FWHM	_
76-44	12813-12814	)	_
76-45	12815-12816	.	_

Text=MEG Group independent component analysis Group-level spatial ICA was performed on the MEG data in the GIFT Toolbox where each frequency band – delta (1–4 Hz), theta (4–8 Hz), alpha (8–13 Hz), beta (13–30 Hz), and gamma (30–50 Hz) – was input as a different session for each individual.
77-1	12817-12820	MEG	_
77-2	12821-12826	Group	_
77-3	12827-12838	independent	_
77-4	12839-12848	component	_
77-5	12849-12857	analysis	_
77-6	12858-12869	Group-level	_
77-7	12870-12877	spatial	_
77-8	12878-12881	ICA	_
77-9	12882-12885	was	_
77-10	12886-12895	performed	_
77-11	12896-12898	on	_
77-12	12899-12902	the	_
77-13	12903-12906	MEG	_
77-14	12907-12911	data	_
77-15	12912-12914	in	_
77-16	12915-12918	the	_
77-17	12919-12923	GIFT	_
77-18	12924-12931	Toolbox	_
77-19	12932-12937	where	_
77-20	12938-12942	each	_
77-21	12943-12952	frequency	_
77-22	12953-12957	band	_
77-23	12958-12959	–	_
77-24	12960-12965	delta	_
77-25	12966-12967	(	_
77-26	12968-12971	1–4	_
77-27	12972-12974	Hz	_
77-28	12975-12976	)	_
77-29	12977-12978	,	_
77-30	12979-12984	theta	_
77-31	12985-12986	(	_
77-32	12987-12990	4–8	_
77-33	12991-12993	Hz	_
77-34	12994-12995	)	_
77-35	12996-12997	,	_
77-36	12998-13003	alpha	_
77-37	13004-13005	(	_
77-38	13006-13010	8–13	_
77-39	13011-13013	Hz	_
77-40	13014-13015	)	_
77-41	13016-13017	,	_
77-42	13018-13022	beta	_
77-43	13023-13024	(	_
77-44	13025-13030	13–30	_
77-45	13031-13033	Hz	_
77-46	13034-13035	)	_
77-47	13036-13037	,	_
77-48	13038-13041	and	_
77-49	13042-13047	gamma	_
77-50	13048-13049	(	_
77-51	13050-13055	30–50	_
77-52	13056-13058	Hz	_
77-53	13059-13060	)	_
77-54	13061-13062	–	_
77-55	13063-13066	was	_
77-56	13067-13072	input	_
77-57	13073-13075	as	_
77-58	13076-13077	a	_
77-59	13078-13087	different	_
77-60	13088-13095	session	_
77-61	13096-13099	for	_
77-62	13100-13104	each	_
77-63	13105-13115	individual	_
77-64	13116-13117	.	_

Text=Similar to fMRI group ICA analysis, MEG data were first reduced to 75 principal components using a subject-specific data reduction PCA and then reduced to 50 principal components via group data reduction.
78-1	13118-13125	Similar	_
78-2	13126-13128	to	_
78-3	13129-13133	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
78-4	13134-13139	group	_
78-5	13140-13143	ICA	_
78-6	13144-13152	analysis	_
78-7	13153-13154	,	_
78-8	13155-13158	MEG	_
78-9	13159-13163	data	_
78-10	13164-13168	were	_
78-11	13169-13174	first	_
78-12	13175-13182	reduced	_
78-13	13183-13185	to	_
78-14	13186-13188	75	_
78-15	13189-13198	principal	_
78-16	13199-13209	components	_
78-17	13210-13215	using	_
78-18	13216-13217	a	_
78-19	13218-13234	subject-specific	_
78-20	13235-13239	data	_
78-21	13240-13249	reduction	_
78-22	13250-13253	PCA	_
78-23	13254-13257	and	_
78-24	13258-13262	then	_
78-25	13263-13270	reduced	_
78-26	13271-13273	to	_
78-27	13274-13276	50	_
78-28	13277-13286	principal	_
78-29	13287-13297	components	_
78-30	13298-13301	via	_
78-31	13302-13307	group	_
78-32	13308-13312	data	_
78-33	13313-13322	reduction	_
78-34	13323-13324	.	_

Text=PCA was carried out using the expectation maximization algorithm.
79-1	13325-13328	PCA	_
79-2	13329-13332	was	_
79-3	13333-13340	carried	_
79-4	13341-13344	out	_
79-5	13345-13350	using	_
79-6	13351-13354	the	_
79-7	13355-13366	expectation	_
79-8	13367-13379	maximization	_
79-9	13380-13389	algorithm	_
79-10	13390-13391	.	_

Text=The infomax algorithm was then utilized for group-level spatial ICA to generate 50 spatially independent components (ICs) (See Supplementary Fig.
80-1	13392-13395	The	_
80-2	13396-13403	infomax	_
80-3	13404-13413	algorithm	_
80-4	13414-13417	was	_
80-5	13418-13422	then	_
80-6	13423-13431	utilized	_
80-7	13432-13435	for	_
80-8	13436-13447	group-level	_
80-9	13448-13455	spatial	_
80-10	13456-13459	ICA	_
80-11	13460-13462	to	_
80-12	13463-13471	generate	_
80-13	13472-13474	50	_
80-14	13475-13484	spatially	_
80-15	13485-13496	independent	_
80-16	13497-13507	components	_
80-17	13508-13509	(	_
80-18	13510-13513	ICs	_
80-19	13514-13515	)	_
80-20	13516-13517	(	_
80-21	13518-13521	See	_
80-22	13522-13535	Supplementary	_
80-23	13536-13539	Fig	_
80-24	13540-13541	.	_

Text=1 for estimation of the number of ICs using minimum description length criteria).
81-1	13542-13543	1	_
81-2	13544-13547	for	_
81-3	13548-13558	estimation	_
81-4	13559-13561	of	_
81-5	13562-13565	the	_
81-6	13566-13572	number	_
81-7	13573-13575	of	_
81-8	13576-13579	ICs	_
81-9	13580-13585	using	_
81-10	13586-13593	minimum	_
81-11	13594-13605	description	_
81-12	13606-13612	length	_
81-13	13613-13621	criteria	_
81-14	13622-13623	)	_
81-15	13624-13625	.	_

Text=Component stability/quality was measured by repeating the infomax ICA algorithm 20 times in ICASSO.
82-1	13626-13635	Component	_
82-2	13636-13653	stability/quality	_
82-3	13654-13657	was	_
82-4	13658-13666	measured	_
82-5	13667-13669	by	_
82-6	13670-13679	repeating	_
82-7	13680-13683	the	_
82-8	13684-13691	infomax	_
82-9	13692-13695	ICA	_
82-10	13696-13705	algorithm	_
82-11	13706-13708	20	_
82-12	13709-13714	times	_
82-13	13715-13717	in	_
82-14	13718-13724	ICASSO	_
82-15	13725-13726	.	_

Text=Subject-specific spatial maps and time courses were estimated using GICA back-reconstruction.
83-1	13727-13743	Subject-specific	_
83-2	13744-13751	spatial	_
83-3	13752-13756	maps	_
83-4	13757-13760	and	_
83-5	13761-13765	time	_
83-6	13766-13773	courses	_
83-7	13774-13778	were	_
83-8	13779-13788	estimated	_
83-9	13789-13794	using	_
83-10	13795-13799	GICA	_
83-11	13800-13819	back-reconstruction	_
83-12	13820-13821	.	_

Text=MEG component identification MEG ICs were classified as RSNs, rather than artifacts, following the same method described in the previous section: fMRI Component Identification.
84-1	13822-13825	MEG	_
84-2	13826-13835	component	_
84-3	13836-13850	identification	_
84-4	13851-13854	MEG	_
84-5	13855-13858	ICs	_
84-6	13859-13863	were	_
84-7	13864-13874	classified	_
84-8	13875-13877	as	_
84-9	13878-13882	RSNs	_
84-10	13883-13884	,	_
84-11	13885-13891	rather	_
84-12	13892-13896	than	_
84-13	13897-13906	artifacts	_
84-14	13907-13908	,	_
84-15	13909-13918	following	_
84-16	13919-13922	the	_
84-17	13923-13927	same	_
84-18	13928-13934	method	_
84-19	13935-13944	described	_
84-20	13945-13947	in	_
84-21	13948-13951	the	_
84-22	13952-13960	previous	_
84-23	13961-13968	section	_
84-24	13969-13970	:	_
84-25	13971-13975	fMRI	_
84-26	13976-13985	Component	_
84-27	13986-14000	Identification	_
84-28	14001-14002	.	_

Text=Of the 50 components extracted, 33 were identified as RSNs (Fig.
85-1	14003-14005	Of	_
85-2	14006-14009	the	_
85-3	14010-14012	50	_
85-4	14013-14023	components	_
85-5	14024-14033	extracted	_
85-6	14034-14035	,	_
85-7	14036-14038	33	_
85-8	14039-14043	were	_
85-9	14044-14054	identified	_
85-10	14055-14057	as	_
85-11	14058-14062	RSNs	_
85-12	14063-14064	(	_
85-13	14065-14068	Fig	_
85-14	14069-14070	.	_

Text=1).
86-1	14071-14072	1	_
86-2	14073-14074	)	_
86-3	14075-14076	.	_

Text=Functional connectivity analysis Functional connectivity analysis Functional connectivity analysis for fMRI and MEG was performed using the spatial maps and corresponding time courses extracted during the ICA analysis.
87-1	14077-14087	Functional	_
87-2	14088-14100	connectivity	_
87-3	14101-14109	analysis	_
87-4	14110-14120	Functional	_
87-5	14121-14133	connectivity	_
87-6	14134-14142	analysis	_
87-7	14143-14153	Functional	_
87-8	14154-14166	connectivity	_
87-9	14167-14175	analysis	_
87-10	14176-14179	for	_
87-11	14180-14184	fMRI	_
87-12	14185-14188	and	_
87-13	14189-14192	MEG	_
87-14	14193-14196	was	_
87-15	14197-14206	performed	_
87-16	14207-14212	using	_
87-17	14213-14216	the	_
87-18	14217-14224	spatial	_
87-19	14225-14229	maps	_
87-20	14230-14233	and	_
87-21	14234-14247	corresponding	_
87-22	14248-14252	time	_
87-23	14253-14260	courses	_
87-24	14261-14270	extracted	_
87-25	14271-14277	during	_
87-26	14278-14281	the	_
87-27	14282-14285	ICA	_
87-28	14286-14294	analysis	_
87-29	14295-14296	.	_

Text=For the fMRI data, framewise displacement was regressed from the subject-specific RSN time courses prior to connectivity analyses.
88-1	14297-14300	For	_
88-2	14301-14304	the	_
88-3	14305-14309	fMRI	_
88-4	14310-14314	data	_
88-5	14315-14316	,	_
88-6	14317-14326	framewise	_
88-7	14327-14339	displacement	_
88-8	14340-14343	was	_
88-9	14344-14353	regressed	_
88-10	14354-14358	from	_
88-11	14359-14362	the	_
88-12	14363-14379	subject-specific	_
88-13	14380-14383	RSN	_
88-14	14384-14388	time	_
88-15	14389-14396	courses	_
88-16	14397-14402	prior	_
88-17	14403-14405	to	_
88-18	14406-14418	connectivity	_
88-19	14419-14427	analyses	_
88-20	14428-14429	.	_

Text=Framewise displacement was computed as the absolute frame-to-frame displacement of the brain from six realignment parameters using a radius of 50 mm to convert angle rotations to displacements.
89-1	14430-14439	Framewise	_
89-2	14440-14452	displacement	_
89-3	14453-14456	was	_
89-4	14457-14465	computed	_
89-5	14466-14468	as	_
89-6	14469-14472	the	_
89-7	14473-14481	absolute	_
89-8	14482-14496	frame-to-frame	_
89-9	14497-14509	displacement	_
89-10	14510-14512	of	_
89-11	14513-14516	the	_
89-12	14517-14522	brain	_
89-13	14523-14527	from	_
89-14	14528-14531	six	_
89-15	14532-14543	realignment	_
89-16	14544-14554	parameters	_
89-17	14555-14560	using	_
89-18	14561-14562	a	_
89-19	14563-14569	radius	_
89-20	14570-14572	of	_
89-21	14573-14575	50	_
89-22	14576-14578	mm	_
89-23	14579-14581	to	_
89-24	14582-14589	convert	_
89-25	14590-14595	angle	_
89-26	14596-14605	rotations	_
89-27	14606-14608	to	_
89-28	14609-14622	displacements	_
89-29	14623-14624	.	_

Text=Therefore, individual displacement values for each volume of the time course (i.e., 120 frame-to-frame displacement values) resulted.
90-1	14625-14634	Therefore	_
90-2	14635-14636	,	_
90-3	14637-14647	individual	_
90-4	14648-14660	displacement	_
90-5	14661-14667	values	_
90-6	14668-14671	for	_
90-7	14672-14676	each	_
90-8	14677-14683	volume	_
90-9	14684-14686	of	_
90-10	14687-14690	the	_
90-11	14691-14695	time	_
90-12	14696-14702	course	_
90-13	14703-14704	(	_
90-14	14705-14709	i.e.	_
90-15	14710-14711	,	_
90-16	14712-14715	120	_
90-17	14716-14730	frame-to-frame	_
90-18	14731-14743	displacement	_
90-19	14744-14750	values	_
90-20	14751-14752	)	_
90-21	14753-14761	resulted	_
90-22	14762-14763	.	_

Text=Framewise displacement was regressed from the subject-specific RSN time courses prior to functional connectivity analysis.
91-1	14764-14773	Framewise	_
91-2	14774-14786	displacement	_
91-3	14787-14790	was	_
91-4	14791-14800	regressed	_
91-5	14801-14805	from	_
91-6	14806-14809	the	_
91-7	14810-14826	subject-specific	_
91-8	14827-14830	RSN	_
91-9	14831-14835	time	_
91-10	14836-14843	courses	_
91-11	14844-14849	prior	_
91-12	14850-14852	to	_
91-13	14853-14863	functional	_
91-14	14864-14876	connectivity	_
91-15	14877-14885	analysis	_
91-16	14886-14887	.	_

Text=It is important to note that mean framewise displacement did not differ between groups [HC: 0.19±0.09 mm (range: 0.07–0.44 mm); SZ: 0.21±0.14 mm (range: 0.04–0.47 mm); t = −0.78, p = .44].
92-1	14888-14890	It	_
92-2	14891-14893	is	_
92-3	14894-14903	important	_
92-4	14904-14906	to	_
92-5	14907-14911	note	_
92-6	14912-14916	that	_
92-7	14917-14921	mean	_
92-8	14922-14931	framewise	_
92-9	14932-14944	displacement	_
92-10	14945-14948	did	_
92-11	14949-14952	not	_
92-12	14953-14959	differ	_
92-13	14960-14967	between	_
92-14	14968-14974	groups	_
92-15	14975-14976	[	_
92-16	14977-14979	HC	_
92-17	14980-14981	:	_
92-18	14982-14991	0.19±0.09	_
92-19	14992-14994	mm	_
92-20	14995-14996	(	_
92-21	14997-15002	range	_
92-22	15003-15004	:	_
92-23	15005-15014	0.07–0.44	_
92-24	15015-15017	mm	_
92-25	15018-15019	)	_
92-26	15020-15021	;	_
92-27	15022-15024	SZ	_
92-28	15025-15026	:	_
92-29	15027-15036	0.21±0.14	_
92-30	15037-15039	mm	_
92-31	15040-15041	(	_
92-32	15042-15047	range	_
92-33	15048-15049	:	_
92-34	15050-15059	0.04–0.47	_
92-35	15060-15062	mm	_
92-36	15063-15064	)	_
92-37	15065-15066	;	_
92-38	15067-15068	t	_
92-39	15069-15070	=	_
92-40	15071-15076	−0.78	_
92-41	15077-15078	,	_
92-42	15079-15080	p	_
92-43	15081-15082	=	_
92-44	15083-15086	.44	_
92-45	15087-15088	]	_
92-46	15089-15090	.	_

Text=No participants exceeded mean framewise displacement of 0.5 mm.
93-1	15091-15093	No	_
93-2	15094-15106	participants	_
93-3	15107-15115	exceeded	_
93-4	15116-15120	mean	_
93-5	15121-15130	framewise	_
93-6	15131-15143	displacement	_
93-7	15144-15146	of	_
93-8	15147-15150	0.5	_
93-9	15151-15153	mm	_
93-10	15154-15155	.	_

Text=The number of head motion outliers (defined as FD> 0.5 mm) did not differ between groups (HC: 5.67±6.51%, SZ: 6.79+/− 7.49%, t = −0.51 p = .62).
94-1	15156-15159	The	_
94-2	15160-15166	number	_
94-3	15167-15169	of	_
94-4	15170-15174	head	_
94-5	15175-15181	motion	_
94-6	15182-15190	outliers	_
94-7	15191-15192	(	_
94-8	15193-15200	defined	_
94-9	15201-15203	as	_
94-10	15204-15206	FD	_
94-11	15207-15208	>	_
94-12	15209-15212	0.5	_
94-13	15213-15215	mm	_
94-14	15216-15217	)	_
94-15	15218-15221	did	_
94-16	15222-15225	not	_
94-17	15226-15232	differ	_
94-18	15233-15240	between	_
94-19	15241-15247	groups	_
94-20	15248-15249	(	_
94-21	15250-15252	HC	_
94-22	15253-15254	:	_
94-23	15255-15264	5.67±6.51	_
94-24	15265-15266	%	_
94-25	15267-15268	,	_
94-26	15269-15271	SZ	_
94-27	15272-15273	:	_
94-28	15274-15281	6.79+/−	_
94-29	15282-15286	7.49	_
94-30	15287-15288	%	_
94-31	15289-15290	,	_
94-32	15291-15292	t	_
94-33	15293-15294	=	_
94-34	15295-15300	−0.51	_
94-35	15301-15302	p	_
94-36	15303-15304	=	_
94-37	15305-15308	.62	_
94-38	15309-15310	)	_
94-39	15311-15312	.	_

Text=Subject-specific fMRI and MEG RSN time courses were detrended and despiked using 3dDespike (http: //afni.nimh.nih.gov/afni) and then filtered with a fifth-order Butterworth low-pass filter (0.15 Hz cutoff) prior to connectivity computation.
95-1	15313-15329	Subject-specific	_
95-2	15330-15334	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
95-3	15335-15338	and	_
95-4	15339-15342	MEG	_
95-5	15343-15346	RSN	_
95-6	15347-15351	time	_
95-7	15352-15359	courses	_
95-8	15360-15364	were	_
95-9	15365-15374	detrended	_
95-10	15375-15378	and	_
95-11	15379-15387	despiked	_
95-12	15388-15393	using	_
95-13	15394-15403	3dDespike	_
95-14	15404-15405	(	_
95-15	15406-15410	http	_
95-16	15411-15412	:	_
95-17	15413-15437	//afni.nimh.nih.gov/afni	_
95-18	15438-15439	)	_
95-19	15440-15443	and	_
95-20	15444-15448	then	_
95-21	15449-15457	filtered	_
95-22	15458-15462	with	_
95-23	15463-15464	a	_
95-24	15465-15476	fifth-order	_
95-25	15477-15488	Butterworth	_
95-26	15489-15497	low-pass	_
95-27	15498-15504	filter	_
95-28	15505-15506	(	_
95-29	15507-15511	0.15	_
95-30	15512-15514	Hz	_
95-31	15515-15521	cutoff	_
95-32	15522-15523	)	_
95-33	15524-15529	prior	_
95-34	15530-15532	to	_
95-35	15533-15545	connectivity	_
95-36	15546-15557	computation	_
95-37	15558-15559	.	_

Text=Functional connectivity was calculated as the pairwise Pearson correlation between RSN time courses, resulting in individual correlation matrices for each subject's fMRI data and MEG frequency bands.
96-1	15560-15570	Functional	_
96-2	15571-15583	connectivity	_
96-3	15584-15587	was	_
96-4	15588-15598	calculated	_
96-5	15599-15601	as	_
96-6	15602-15605	the	_
96-7	15606-15614	pairwise	_
96-8	15615-15622	Pearson	_
96-9	15623-15634	correlation	_
96-10	15635-15642	between	_
96-11	15643-15646	RSN	_
96-12	15647-15651	time	_
96-13	15652-15659	courses	_
96-14	15660-15661	,	_
96-15	15662-15671	resulting	_
96-16	15672-15674	in	_
96-17	15675-15685	individual	_
96-18	15686-15697	correlation	_
96-19	15698-15706	matrices	_
96-20	15707-15710	for	_
96-21	15711-15715	each	_
96-22	15716-15723	subject	_
96-23	15724-15726	's	_
96-24	15727-15731	fMRI	_
96-25	15732-15736	data	_
96-26	15737-15740	and	_
96-27	15741-15744	MEG	_
96-28	15745-15754	frequency	_
96-29	15755-15760	bands	_
96-30	15761-15762	.	_

Text=Time courses were extracted from the independent components obtained by ICA.
97-1	15763-15767	Time	_
97-2	15768-15775	courses	_
97-3	15776-15780	were	_
97-4	15781-15790	extracted	_
97-5	15791-15795	from	_
97-6	15796-15799	the	_
97-7	15800-15811	independent	_
97-8	15812-15822	components	_
97-9	15823-15831	obtained	_
97-10	15832-15834	by	_
97-11	15835-15838	ICA	_
97-12	15839-15840	.	_

Text=Correlations were based on the average time course across voxels within each independent component.
98-1	15841-15853	Correlations	_
98-2	15854-15858	were	_
98-3	15859-15864	based	_
98-4	15865-15867	on	_
98-5	15868-15871	the	_
98-6	15872-15879	average	_
98-7	15880-15884	time	_
98-8	15885-15891	course	_
98-9	15892-15898	across	_
98-10	15899-15905	voxels	_
98-11	15906-15912	within	_
98-12	15913-15917	each	_
98-13	15918-15929	independent	_
98-14	15930-15939	component	_
98-15	15940-15941	.	_

Text=Individual correlation matrices were averaged across subjects in each group in order to generate group-level connectivity matrices.
99-1	15942-15952	Individual	_
99-2	15953-15964	correlation	_
99-3	15965-15973	matrices	_
99-4	15974-15978	were	_
99-5	15979-15987	averaged	_
99-6	15988-15994	across	_
99-7	15995-16003	subjects	_
99-8	16004-16006	in	_
99-9	16007-16011	each	_
99-10	16012-16017	group	_
99-11	16018-16020	in	_
99-12	16021-16026	order	_
99-13	16027-16029	to	_
99-14	16030-16038	generate	_
99-15	16039-16050	group-level	_
99-16	16051-16063	connectivity	_
99-17	16064-16072	matrices	_
99-18	16073-16074	.	_

Text=Within- and between-group differences in functional connectivity were evaluated on subject-level correlation matrices via paired and two-sample univariate t-tests, respectively.
100-1	16075-16082	Within-	_
100-2	16083-16086	and	_
100-3	16087-16100	between-group	_
100-4	16101-16112	differences	_
100-5	16113-16115	in	_
100-6	16116-16126	functional	_
100-7	16127-16139	connectivity	_
100-8	16140-16144	were	_
100-9	16145-16154	evaluated	_
100-10	16155-16157	on	_
100-11	16158-16171	subject-level	_
100-12	16172-16183	correlation	_
100-13	16184-16192	matrices	_
100-14	16193-16196	via	_
100-15	16197-16203	paired	_
100-16	16204-16207	and	_
100-17	16208-16218	two-sample	_
100-18	16219-16229	univariate	_
100-19	16230-16237	t-tests	_
100-20	16238-16239	,	_
100-21	16240-16252	respectively	_
100-22	16253-16254	.	_

Text=In exploratory post hoc analyses, the relationship between functional connectivity and symptom scores including, BPRS, SAPS, and SANS was explored using Spearman correlations in order to examine the potential impact of symptoms on functional connectivity.
101-1	16255-16257	In	_
101-2	16258-16269	exploratory	_
101-3	16270-16274	post	_
101-4	16275-16278	hoc	_
101-5	16279-16287	analyses	_
101-6	16288-16289	,	_
101-7	16290-16293	the	_
101-8	16294-16306	relationship	_
101-9	16307-16314	between	_
101-10	16315-16325	functional	_
101-11	16326-16338	connectivity	_
101-12	16339-16342	and	_
101-13	16343-16350	symptom	_
101-14	16351-16357	scores	_
101-15	16358-16367	including	_
101-16	16368-16369	,	_
101-17	16370-16374	BPRS	http://maven.renci.org/NeuroBridge/neurobridge#BriefPsychiatricRatingScale
101-18	16375-16376	,	_
101-19	16377-16381	SAPS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms
101-20	16382-16383	,	_
101-21	16384-16387	and	_
101-22	16388-16392	SANS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms
101-23	16393-16396	was	_
101-24	16397-16405	explored	_
101-25	16406-16411	using	_
101-26	16412-16420	Spearman	_
101-27	16421-16433	correlations	_
101-28	16434-16436	in	_
101-29	16437-16442	order	_
101-30	16443-16445	to	_
101-31	16446-16453	examine	_
101-32	16454-16457	the	_
101-33	16458-16467	potential	_
101-34	16468-16474	impact	_
101-35	16475-16477	of	_
101-36	16478-16486	symptoms	_
101-37	16487-16489	on	_
101-38	16490-16500	functional	_
101-39	16501-16513	connectivity	_
101-40	16514-16515	.	_

